Musculoskeletal Diseases - Ontology Report

Help | FTP Download | Citing RGD | Contact Us

Keyword

ONTOLOGY REPORT - ANNOTATIONS

Term:	Musculoskeletal Diseases	go back to main search page
Accession:	RDO:0001084	browse the term
Definition:	Diseases of the muscles and their associated ligaments and other connective tissue and of the bones and cartilage viewed collectively.
Synonyms:	exact_synonym:	Musculoskeletal Disease
	primary_id:	MESH:D009140

Rat
Mouse
Human
All
show annotations for term's descendants
Sort by:

Musculoskeletal Diseases
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Npr3	natriuretic peptide receptor C/guanylate cyclase C (atrionatriuretic peptide receptor C)			ISS	2	61,278,264	61,341,460	RGD:1580774	RGD
Aarskog syndrome
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Fgd1	FYVE, RhoGEF and PH domain containing 1			ISS	X	40,364,211	40,407,213	RGD:7240710	OMIM
Acheiropodia
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Lmbr1	limb region 1 homolog (mouse)			ISS	4	1,177,941	1,344,583	RGD:7240710	OMIM
Acrocapitofemoral Dysplasia
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Ihh	Indian hedgehog			ISS	9	74,287,115	74,293,332	RGD:7240710	OMIM
Acrocephalopolysyndactyly Type II
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Rab23	RAB23, member RAS oncogene family			ISS	9	32,465,752	32,486,615	RGD:7240710	OMIM
Acrocephalosyndactylia
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Fgfr1	Fibroblast growth factor receptor 1			ISS	16	70,869,974	70,910,045	RGD:704404	RGD
G	Fgfr1	Fibroblast growth factor receptor 1			ISS	16	70,869,974	70,910,045	RGD:7240710	OMIM
G	Fgfr2	fibroblast growth factor receptor 2			ISS	1	189,482,975	189,589,279	RGD:704404	RGD
G	Fgfr2	fibroblast growth factor receptor 2			ISS	1	189,482,975	189,589,279	RGD:7240710	OMIM
G	Twist1	twist basic helix-loop-helix transcription factor 1			ISS	6	52,605,869	52,607,863	RGD:1624353	RGD
G	Twist1	twist basic helix-loop-helix transcription factor 1			ISS	6	52,605,869	52,607,863	RGD:7240710	OMIM
Acyl-CoA Dehydrogenase Family, Member 9, Deficiency of
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Acad9	acyl-CoA dehydrogenase family, member 9			ISS	2	122,562,974	122,585,953	RGD:7240710	OMIM
Al Awadi syndrome
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Wnt7a	wingless-type MMTV integration site family, member 7A			ISS	4	125,541,281	125,586,167	RGD:7240710	OMIM
Alpha-B Crystallinopathy
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Cryab	crystallin, alpha B			ISS	8	54,107,824	54,111,502	RGD:7240710	OMIM
Amish lethal microcephaly
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Slc25a19	solute carrier family 25 (mitochondrial thiamine pyrophosphate carrier), member 19			ISS	10	105,694,526	105,707,452	RGD:7240710	OMIM
Amyopathic dermatomyositis
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	RT1-Ba	RT1 class II, locus Ba			ISS	20	4,697,971	4,702,564	RGD:5147796	RGD
G	RT1-Ba	RT1 class II, locus Ba			ISS	20	4,697,971	4,702,564	RGD:5147790	RGD
Angiopathy, Hereditary, With Nephropathy, Aneurysms, And Muscle Cramps
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Col4a1	collagen, type IV, alpha 1			ISS	16	83,045,183	83,157,835	RGD:7240710	OMIM
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Por	P450 (cytochrome) oxidoreductase			ISS	12	22,078,629	22,097,301	RGD:7240710	OMIM
ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Fgfr2	fibroblast growth factor receptor 2			ISS	1	189,482,975	189,589,279	RGD:7240710	OMIM
Aortic aneurysm, familial thoracic 3
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Tgfbr2	transforming growth factor, beta receptor II			ISS	8	120,593,595	120,680,453	RGD:7240710	OMIM
Arterial Tortuosity Syndrome
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Slc2a10	solute carrier family 2 (facilitated glucose transporter), member 10			ISS	3	156,560,451	156,572,777	RGD:7240710	OMIM
Arthritis
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Ankh	ankylosis, progressive homolog (mouse)			ISS	2	79,289,427	79,418,518	RGD:734569	RGD
G	B2m	beta-2 microglobulin			ISS	3	108,927,919	108,932,718	RGD:6482692	RGD
G	Cnr2	cannabinoid receptor 2 (macrophage)			IPM	5	154,674,754	154,702,552	RGD:2316223	RGD
G	Fcgr3a	Fc fragment of IgG, low affinity IIIa, receptor			ISS	13	86,867,641	86,877,665	RGD:5508443	RGD
G	Fcgr3a	Fc fragment of IgG, low affinity IIIa, receptor		Susceptibility	ISS	13	86,867,641	86,877,665	RGD:5508432	RGD
G	Gc	group specific component		Susceptibility	ISS	14	20,166,243	20,197,060	RGD:5509918	RGD
G	Ncf1	neutrophil cytosolic factor 1			QTM	12	23,578,097	23,587,292	RGD:628543	RGD
G	Parp1	poly (ADP-ribose) polymerase 1			ISS	13	96,309,670	96,341,486	RGD:1601085	RGD
G	RT1-Ba	RT1 class II, locus Ba			ISS	20	4,697,971	4,702,564	RGD:5147787	RGD
G	RT1-Bb	RT1 class II, locus Bb			ISS	20	4,730,559	4,736,201	RGD:5147787	RGD
G	Sele	selectin E			ISS	13	79,813,455	79,822,845	RGD:1580041	RGD
S	ACI/SegHsd			Resistance	TAS				RGD:1285224	RGD
S	AVN				TAS				RGD:1004	RGD
S	DA.E3-(D14Wox8-D14Rat64)/Rhd				QTM	14	68,573,958	68,574,165	RGD:730280	RGD
S	DA.E3-(D6Wox5-D6Rat90)/Rhd				IED	6	117,361,909	117,362,003	RGD:728382	RGD
S	DA.F344-(D10Arb21-D10Arb22)				TAS	10	14,721,135	14,721,325	RGD:631168	RGD
S	DA.F344-(D10Rat204-D10Arb22)/Arb				QTM	10	95,695,076	95,695,218	RGD:629569	RGD
S	DA.F344-(D10Rat37-D10Arb22)				TAS	10	24,006,429	24,006,612	RGD:631168	RGD
S	DA.F344-(D4Arb30-D4Arb4)/Arb				QTM	4	73,972,453	154,937,227	RGD:629569	RGD
S	DA.F344-(D7Arb5-D7Mit2)/Arb				QTM	7	98,955,064	123,191,874	RGD:629569	RGD
S	DA.F344-(D8Arb15-D8Arb22)/Arb				QTM	8	71,843,628	124,310,337	RGD:629569	RGD
S	DA.PVG.1AV1-(D4Mgh17-D4Rat56)				QTM	4	116,611,031	143,663,540	RGD:629560	RGD
S	DA.PVG.1AV1-(D4Rat155-D4Rat84)				QTM	4	185,398,415	185,398,530	RGD:629560	RGD
S	DA.PVG.1AV1-(D4Rat155-Spr)				IED	4	119,365,578	119,369,308	RGD:629560	RGD
S	DA.PVG.1AV1-(D4Rat63-D4Rat203)				QTM	4	156,442,644	161,435,775	RGD:629560	RGD
S	DA/BklArbN			Susceptibility	TAS				RGD:1285224	RGD
S	DA/ZtmRhd				TAS				RGD:631850	RGD
S	DXE1/Ztm				TAS				RGD:61088	RGD
S	DXE2/Ztm				TAS				RGD:61088	RGD
S	DXE3/Ztm				TAS				RGD:61088	RGD
S	E3/ZtmRhd				TAS				RGD:631850	RGD
S	F344.DA-(D20Arb2-D20Arb8)/Arb				QTM	20	2,790,511	2,811,567	RGD:629569	RGD
S	LEW-Tg(HLA-B*2705m1,B2M)133-1Trg				QTM				RGD:731214	RGD
S	LEW.1AV1				TAS				RGD:737659	RGD
S	LEW.1AV1				QTM				RGD:61087	RGD
S	LEW/Ztm	LEW/Ztm			TAS				RGD:1299867	RGD
Arthritis, Infectious
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Ccl4	chemokine (C-C motif) ligand 4			ISS	10	71,759,643	71,761,115	RGD:5683892	RGD
Arthritis, Juvenile Rheumatoid
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Ccr5	chemokine (C-C motif) receptor 5		No_Association	ISS	8	128,907,157	128,912,272	RGD:1626283	RGD
G	Ccr5	chemokine (C-C motif) receptor 5			ISS	8	128,907,157	128,912,272	RGD:1626284	RGD
G	Ciita	class II, major histocompatibility complex, transactivator		Resistance	ISS	10	5,087,174	5,133,418	RGD:5491187	RGD
G	Ciita	class II, major histocompatibility complex, transactivator		No_Association	ISS	10	5,087,174	5,133,418	RGD:5491189	RGD
G	Crp	C-reactive protein, pentraxin-related			ISS	13	88,702,243	88,703,153	RGD:6906884	RGD
G	Gstt1	glutathione S-transferase theta 1		Susceptibility	ISS	20	13,604,355	13,621,456	RGD:5490992	RGD
G	Hgf	hepatocyte growth factor			ISS	4	14,864,357	14,932,513	RGD:7240710	OMIM
G	Il2	interleukin 2			ISS	2	123,655,005	123,659,709	RGD:5147870	RGD
G	Il6	interleukin 6			ISS	4	456,799	461,376	RGD:7240710	OMIM
G	Mif	macrophage migration inhibitory factor (glycosylation-inhibiting factor)			ISS	20	13,191,986	13,192,851	RGD:7240710	OMIM
G	Ptpn22	protein tyrosine phosphatase, non-receptor type 22 (lymphoid)			ISS	2	199,083,186	199,144,309	RGD:6484550	RGD
G	RT1-Ba	RT1 class II, locus Ba			ISS	20	4,697,971	4,702,564	RGD:5147815	RGD
G	RT1-Ba	RT1 class II, locus Ba			ISS	20	4,697,971	4,702,564	RGD:5147863	RGD
G	RT1-Bb	RT1 class II, locus Bb			ISS	20	4,730,559	4,736,201	RGD:5147863	RGD
G	RT1-Db1	RT1 class II, locus Db1			ISS	20	4,671,489	4,681,058	RGD:5147587	RGD
G	RT1-Db1	RT1 class II, locus Db1			ISS	20	4,671,489	4,681,058	RGD:5147863	RGD
G	Selp	selectin P		Severity	ISS	13	79,886,614	79,922,180	RGD:6219006	RGD
G	Sh2d2a	SH2 domain containing 2A			ISS	2	179,916,108	179,924,623	RGD:2298870	RGD
G	Slc11a1	solute carrier family 11 (proton-coupled divalent metal ion transporters), member 1			ISS	9	73,714,692	73,725,523	RGD:5684977	RGD
G	Thbd	thrombomodulin			ISS	3	137,158,955	137,162,607	RGD:5685023	RGD
S	DA.E3-(D20Wox3-D20Mgh4)/Rhd				IED	20	3,660,646	6,880,472	RGD:631850	RGD
Arthritis, Reactive
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Cyp1a1	cytochrome P450, family 1, subfamily a, polypeptide 1			ISS	8	61,462,207	61,468,237	RGD:1581251	RGD
G	Sod2	superoxide dismutase 2, mitochondrial			ISS	1	41,862,997	41,870,327	RGD:1581251	RGD
G	Tap1	transporter 1, ATP-binding cassette, sub-family B (MDR/TAP)			ISS	20	4,790,363	4,800,730	RGD:6482278	RGD
G	Tap2	transporter 2, ATP-binding cassette, sub-family B (MDR/TAP)			ISS	20	4,770,446	4,784,488	RGD:6482278	RGD
Arthritis, Rheumatoid
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	A2m	alpha-2-macroglobulin			IEA	4	158,103,711	158,153,423	RGD:1331525	RGD
G	Adipoq	adiponectin, C1Q and collagen domain containing			ISS	11	79,908,291	79,911,065	RGD:5686424	RGD
G	Adrb3	adrenoceptor beta 3			ISS	16	69,163,620	69,166,384	RGD:5684893	RGD
G	Adrbk1	adrenergic, beta, receptor kinase 1			ISS	1	206,873,002	206,892,868	RGD:5688373	RGD
G	Adrbk1	adrenergic, beta, receptor kinase 1			ISS	1	206,873,002	206,892,868	RGD:5688380	RGD
G	Ager	advanced glycosylation end product-specific receptor			ISS	20	4,250,613	4,253,540	RGD:704409	RGD
G	Ang	angiogenin, ribonuclease, RNase A family, 5			ISS	15	27,083,089	27,083,526	RGD:6892721	RGD
G	Apoa4	apolipoprotein A-IV			ISS	8	49,233,142	49,233,431	RGD:5685646	RGD
G	Bglap	bone gamma-carboxyglutamate (gla) protein			ISS	2	180,482,313	180,483,290	RGD:6483600	RGD
G	Bglap	bone gamma-carboxyglutamate (gla) protein			ISS	2	180,482,313	180,483,290	RGD:6483593	RGD
G	Bst1	bone marrow stromal cell antigen 1			ISS	14	72,404,263	72,414,500	RGD:704409	RGD
G	C4b	complement component 4B (Chido blood group)			ISS	20	4,300,687	4,315,882	RGD:5688263	RGD
G	Casp7	caspase 7			ISS	1	262,689,300	262,721,591	RGD:5684540	RGD
G	Cast	calpastatin			ISS	2	1,495,048	1,608,477	RGD:5683620	RGD
G	Ccl2	chemokine (C-C motif) ligand 2			ISS	10	70,256,263	70,258,061	RGD:4891442	RGD
G	Ccr1	chemokine (C-C motif) receptor 1			ISS	8	128,693,658	128,699,213	RGD:5688170	RGD
G	Ccr3	chemokine (C-C motif) receptor 3			ISS	8	128,759,943	128,769,341	RGD:4145632	RGD
G	Ccr5	chemokine (C-C motif) receptor 5		No_Association	ISS	8	128,907,157	128,912,272	RGD:1626283	RGD
G	Ccr5	chemokine (C-C motif) receptor 5		Resistance	ISS	8	128,907,157	128,912,272	RGD:1626290	RGD
G	Cd244	Cd244 molecule, natural killer cell receptor 2B4			ISS	13	87,513,413	87,531,211	RGD:7240710	OMIM
G	Cd28	Cd28 molecule			ISS	9	59,342,273	59,367,743	RGD:5131619	RGD
G	Cd40	CD40 molecule, TNF receptor superfamily member 5			ISS	3	156,092,602	156,107,427	RGD:5490972	RGD
G	Cd80	Cd80 molecule			ISS	11	64,045,358	64,070,072	RGD:6893647	RGD
G	Chi3l1	chitinase 3-like 1 (cartilage glycoprotein-39)		Severity	ISS	13	47,139,658	47,147,591	RGD:4892605	RGD
G	Ciita	class II, major histocompatibility complex, transactivator		Susceptibility	ISS	10	5,087,174	5,133,418	RGD:1358146	RGD
G	Ciita	class II, major histocompatibility complex, transactivator		No_Association	ISS	10	5,087,174	5,133,418	RGD:5491189	RGD
G	Ciita	class II, major histocompatibility complex, transactivator			ISS	10	5,087,174	5,133,418	RGD:5491176	RGD
G	Clec16a	C-type lectin domain family 16, member A			ISS	10	4,870,719	5,069,691	RGD:5491176	RGD
G	Crp	C-reactive protein, pentraxin-related			IED	13	88,702,243	88,703,153	RGD:6904209	RGD
G	Crp	C-reactive protein, pentraxin-related			ISS	13	88,702,243	88,703,153	RGD:6904209	RGD
G	Cx3cl1	chemokine (C-X3-C motif) ligand 1			ISS	19	10,666,940	10,676,424	RGD:4892002	RGD
G	Cxcr3	chemokine (C-X-C motif) receptor 3			ISS	X	89,794,276	89,796,927	RGD:4145632	RGD
G	Esr2	estrogen receptor 2 (ER beta)		Severity	ISS	6	98,691,167	98,775,299	RGD:5508794	RGD
G	F2rl1	coagulation factor II (thrombin) receptor-like 1			ISS	2	25,886,177	25,899,128	RGD:735010	RGD
G	Fcgr2a	Fc fragment of IgG, low affinity IIa, receptor			ISS	13	86,898,651	86,911,743	RGD:5147984	RGD
G	Fcgr2a	Fc fragment of IgG, low affinity IIa, receptor			ISS	13	86,898,651	86,911,743	RGD:5147978	RGD
G	Fcgr3a	Fc fragment of IgG, low affinity IIIa, receptor		Susceptibility	ISS	13	86,867,641	86,877,665	RGD:5508391	RGD
G	Fcgr3a	Fc fragment of IgG, low affinity IIIa, receptor			ISS	13	86,867,641	86,877,665	RGD:5508467	RGD
G	Gc	group specific component			ISS	14	20,166,243	20,197,060	RGD:5509931	RGD
G	Grk5	G protein-coupled receptor kinase 5		No_Association	ISS	1	267,495,534	267,693,144	RGD:5688373	RGD
G	Grk5	G protein-coupled receptor kinase 5		No_Association	ISS	1	267,495,534	267,693,144	RGD:5688380	RGD
G	Grk6	G protein-coupled receptor kinase 6			ISS	17	15,220,992	15,236,617	RGD:5688380	RGD
G	Grk6	G protein-coupled receptor kinase 6			ISS	17	15,220,992	15,236,617	RGD:5688373	RGD
G	Gstm1	glutathione S-transferase mu 1			ISS	2	203,575,444	203,580,821	RGD:5490993	RGD
G	Gstm1	glutathione S-transferase mu 1		Susceptibility	ISS	2	203,575,444	203,580,821	RGD:5490994	RGD
G	Gstm1	glutathione S-transferase mu 1		Susceptibility	ISS	2	203,575,444	203,580,821	RGD:5490998	RGD
G	Gstt1	glutathione S-transferase theta 1		Susceptibility	ISS	20	13,604,355	13,621,456	RGD:5490983	RGD
G	Gstt1	glutathione S-transferase theta 1			ISS	20	13,604,355	13,621,456	RGD:5490982	RGD
G	Gstt1	glutathione S-transferase theta 1		Severity	ISS	20	13,604,355	13,621,456	RGD:5490553	RGD
G	Hspa4	heat shock protein 4			ISS	10	38,705,629	38,749,058	RGD:5688784	RGD
G	Hspa5	heat shock protein 5			ISS	3	13,783,825	13,788,022	RGD:5685639	RGD
G	Igf2	insulin-like growth factor 2			ISS	1	202,906,624	202,915,231	RGD:5510014	RGD
G	Igf2	insulin-like growth factor 2			ISS	1	202,906,624	202,915,231	RGD:5510001	RGD
G	Il10	interleukin 10			ISS	13	43,953,900	43,957,766	RGD:7240710	OMIM
G	Il1a	interleukin 1 alpha			ISS	3	116,913,612	116,924,114	RGD:4142818	RGD
G	Il1b	interleukin 1 beta			ISS	3	116,964,422	116,970,867	RGD:6482656	RGD
G	Il1rn	interleukin 1 receptor antagonist			ISS	3	2,607,800	2,613,216	RGD:7174696	RGD
G	Il20	interleukin 20			ISS	13	43,860,611	43,863,964	RGD:5147395	RGD
G	Il21r	interleukin 21 receptor			ISS	1	184,665,737	184,693,583	RGD:6892964	RGD
G	Il3	interleukin 3			ISS	10	39,684,691	39,687,041	RGD:5686905	RGD
G	Il5	interleukin 5			ISS	10	39,177,786	39,180,657	RGD:5687156	RGD
G	Jak2	Janus kinase 2			ISS	1	232,915,995	232,974,763	RGD:6483024	RGD
G	Lrrk2	leucine-rich repeat kinase 2			ISS	7	130,105,902	130,267,747	RGD:5508419	RGD
G	Mdk	midkine			ISS	3	76,309,988	76,311,345	RGD:1581200	RGD
G	Mmp1	matrix metallopeptidase 1 (interstitial collagenase)			ISS	8	4,333,773	4,354,284	RGD:7207129	RGD
G	Mmp3	matrix metallopeptidase 3			ISS	8	4,315,601	4,329,146	RGD:7241254	RGD
G	Mmp3	matrix metallopeptidase 3			ISS	8	4,315,601	4,329,146	RGD:7207128	RGD
G	Mmp8	matrix metallopeptidase 8			ISS	8	4,402,124	4,410,976	RGD:7207131	RGD
G	Mmp9	matrix metallopeptidase 9			ISS	3	155,985,473	155,993,433	RGD:1582623	RGD
G	Mt-nd1	mitochondrially encoded NADH dehydrogenase 1			ISS	MT	2,740	3,694	RGD:5490238	RGD
G	Nfkbil1	nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 1			ISS	20	3,629,246	3,644,222	RGD:1331681	RGD
G	Nfkbil1	nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 1			ISS	20	3,629,246	3,644,222	RGD:7240710	OMIM
G	Notch4	notch 4			ISS	20	4,263,205	4,287,312	RGD:6480790	RGD
G	Npsr1	neuropeptide S receptor 1			ISS	8	23,736,081	23,970,242	RGD:4891930	RGD
G	Nr3c1	nuclear receptor subfamily 3, group C, member 1			IEP	18	32,371,496	32,459,145	RGD:4892311	RGD
G	Padi4	peptidyl arginine deiminase, type IV			ISS	5	159,580,718	159,614,628	RGD:7240710	OMIM
G	Pdgfb	platelet-derived growth factor beta polypeptide			ISS	7	118,244,385	118,262,021	RGD:6482653	RGD
G	Pgf	placental growth factor			ISS	6	109,215,540	109,226,122	RGD:6483591	RGD
G	Pla2g7	phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma)			ISS	9	13,057,988	13,100,289	RGD:6482776	RGD
G	Plaur	plasminogen activator, urokinase receptor			ISS	1	79,708,646	79,712,881	RGD:6484117	RGD
G	Ptgs2	prostaglandin-endoperoxide synthase 2			ISS	13	64,427,288	64,432,978	RGD:5508313	RGD
G	Ptpn22	protein tyrosine phosphatase, non-receptor type 22 (lymphoid)			ISS	2	199,083,186	199,144,309	RGD:6484595	RGD
G	Ptpn22	protein tyrosine phosphatase, non-receptor type 22 (lymphoid)			ISS	2	199,083,186	199,144,309	RGD:6484535	RGD
G	Ptpn22	protein tyrosine phosphatase, non-receptor type 22 (lymphoid)			ISS	2	199,083,186	199,144,309	RGD:7240710	OMIM
G	RT1-Ba	RT1 class II, locus Ba			ISS	20	4,697,971	4,702,564	RGD:5147860	RGD
G	RT1-Ba	RT1 class II, locus Ba			ISS	20	4,697,971	4,702,564	RGD:5147859	RGD
G	RT1-Bb	RT1 class II, locus Bb			ISS	20	4,730,559	4,736,201	RGD:5147860	RGD
G	RT1-Db1	RT1 class II, locus Db1			ISS	20	4,671,489	4,681,058	RGD:4144826	RGD
G	RT1-Db1	RT1 class II, locus Db1			ISS	20	4,671,489	4,681,058	RGD:5147616	RGD
G	RT1-Db1	RT1 class II, locus Db1		Susceptibility	ISS	20	4,671,489	4,681,058	RGD:5147567	RGD
G	RT1-Db1	RT1 class II, locus Db1			ISS	20	4,671,489	4,681,058	RGD:5147860	RGD
G	RT1-Db1	RT1 class II, locus Db1			ISS	20	4,671,489	4,681,058	RGD:7240710	OMIM
G	Runx1	runt-related transcription factor 1		No_Association	ISS	11	32,623,461	32,725,404	RGD:6482837	RGD
G	Runx1	runt-related transcription factor 1			ISS	11	32,623,461	32,725,404	RGD:6482836	RGD
G	Runx1	runt-related transcription factor 1		No_Association	ISS	11	32,623,461	32,725,404	RGD:6482840	RGD
G	Runx1	runt-related transcription factor 1		No_Association	ISS	11	32,623,461	32,725,404	RGD:6482839	RGD
G	Sema3c	sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C			ISS	4	13,739,659	13,914,636	RGD:1580084	RGD
G	Slc11a1	solute carrier family 11 (proton-coupled divalent metal ion transporters), member 1		Severity	ISS	9	73,714,692	73,725,523	RGD:5684967	RGD
G	Slc11a1	solute carrier family 11 (proton-coupled divalent metal ion transporters), member 1			ISS	9	73,714,692	73,725,523	RGD:5684971	RGD
G	Spp1	secreted phosphoprotein 1			ISS				RGD:1581382	RGD
G	Stat3	signal transducer and activator of transcription 3 (acute-phase response factor)			ISS	10	89,821,078	89,872,970	RGD:6892936	RGD
G	Stat4	signal transducer and activator of transcription 4			ISS	9	46,510,251	46,650,076	RGD:7240710	OMIM
G	Tap2	transporter 2, ATP-binding cassette, sub-family B (MDR/TAP)			ISS	20	4,770,446	4,784,488	RGD:6482275	RGD
G	Thbd	thrombomodulin			ISS	3	137,158,955	137,162,607	RGD:5685020	RGD
G	Vim	vimentin			ISS	17	87,847,280	87,855,763	RGD:6480508	RGD
Q	Aia10	Adjuvant induced arthritis QTL 10		Induced	IAGP	15	83,677,810	109,758,846	RGD:2316974	RGD
Q	Aia11	Adjuvant induced arthritis QTL 11		Induced	IAGP	17	71,569,891	77,806,121	RGD:2316974	RGD
Q	Aia12	Adjuvant induced arthritis QTL 12		Induced	IAGP	17	49,069,974	94,069,974	RGD:2316974	RGD
Q	Aia13	Adjuvant induced arthritis QTL 13		Induced	IAGP	2	77,630,629	79,118,861	RGD:2316974	RGD
Q	Aia14	Adjuvant induced arthritis QTL 14		Induced	IAGP				RGD:2316974	RGD
Q	Aia15	Adjuvant induced arthritis QTL 15		Induced	IAGP	7	21,202,126	66,202,126	RGD:2316974	RGD
Q	Aia16	Adjuvant induced arthritis QTL 16		Induced	IAGP	7	65,025,373	110,025,373	RGD:2316974	RGD
Q	Aia17	Adjuvant induced arthritis QTL 17		Induced	IAGP	7	87,525,274	132,525,274	RGD:2316974	RGD
Q	Aia18	Adjuvant induced arthritis QTL 18		Induced	IAGP	8	10,116,155	55,116,155	RGD:2316974	RGD
Q	Aia19	Adjuvant induced arthritis QTL 19		Induced	IAGP	10	70,229,781	115,229,781	RGD:2316974	RGD
Q	Aia20	Adjuvant induced arthritis QTL 20		Induced	IAGP	10	41,317,054	86,317,054	RGD:2316974	RGD
Q	Aia21	Adjuvant induced arthritis QTL 21		Induced	IAGP	13	10,688,543	55,688,543	RGD:2316974	RGD
Q	Aia22	Adjuvant induced arthritis QTL 22		Induced	IAGP	13	1	23,584,369	RGD:2316974	RGD
Q	Aia23	Adjuvant induced arthritis QTL 23		Induced	IAGP	13	1,084,268	33,188,609	RGD:2316974	RGD
Q	Aia24	Adjuvant induced arthritis QTL 24		Induced	IAGP	15	58,412,001	80,362,100	RGD:2316974	RGD
Q	Aia25	Adjuvant induced arthritis QTL 25		Induced	IAGP	17	59,104,944	71,569,891	RGD:2316974	RGD
Q	Aia26	Adjuvant induced arthritis QTL 26		Induced	IAGP	17	49,069,974	94,069,974	RGD:2316974	RGD
Q	Aia27	Adjuvant induced arthritis QTL 27		Induced	IAGP	20	3,039,759	37,383,914	RGD:2316974	RGD
Q	Aia6	Adjuvant induced arthritis QTL 6		Induced	IAGP	10	70,229,781	115,229,781	RGD:2316974	RGD
Q	Aia7	Adjuvant induced arthritis QTL 7		Induced	IAGP	10	41,317,054	86,317,054	RGD:2316974	RGD
Q	Aia8	Adjuvant induced arthritis QTL 8		Induced	IAGP	13	10,688,543	55,688,543	RGD:2316974	RGD
Q	Aia9	Adjuvant induced arthritis QTL 9		Induced	IAGP	13	1,084,268	33,188,609	RGD:2316974	RGD
Q	Apr1	Acute phase response QTL 1			IED	12	20,418,353	46,782,294	RGD:629561	RGD
Q	Apr2	Acute phase response QTL 2			IED	5	142,573,432	173,096,209	RGD:629561	RGD
Q	Apr3	Acute phase response QTL 3			IED	10	16,579,339	61,579,339	RGD:629561	RGD
Q	Apr4	Acute phase response QTL 4			IED	12	2,248,421	46,782,294	RGD:629561	RGD
Q	Apr5	Acute phase response QTL 5			IED	12	568,621	45,568,621	RGD:629561	RGD
Q	Apr6	Acute phase response QTL 6			IED	14	1	42,665,455	RGD:629561	RGD
Q	Cia1	Collagen induced arthritis QTL 1			IED	20	3,660,646	14,605,852	RGD:61062	RGD
Q	Cia10	Collagen induced arthritis QTL 10			IED	2	188,136,088	233,136,088	RGD:61063	RGD
Q	Cia11	Collagen induced arthritis QTL 11			IED	3	26,674,018	97,524,000	RGD:61066	RGD
Q	Cia12	Collagen induced arthritis QTL 12			IED	12	7,148,164	36,894,750	RGD:61066	RGD
Q	Cia13	Collagen induced arthritis QTL 13			IED	4	134,858,561	171,204,531	RGD:61067	RGD
Q	Cia14	Collagen induced arthritis QTL 14			IED	19	24,304,442	45,692,656	RGD:61066	RGD
Q	Cia15	Collagen induced arthritis QTL 15			IED	9	2,948,882	39,821,284	RGD:61067	RGD
Q	Cia16	Collagen induced arthritis QTL 16			IED	10	6,380,753	100,633,982	RGD:61067	RGD
Q	Cia17	Collagen induced arthritis QTL 17			IED	18	32,458,819	73,666,623	RGD:61067	RGD
Q	Cia18	Collagen induced arthritis QTL 18			IED	X	4,384,157	49,384,157	RGD:61067	RGD
Q	Cia19	Collagen induced arthritis QTL 19			IED	X	1	88,514,313	RGD:61067	RGD
Q	Cia2	Collagen induced arthritis QTL 2			IED	1	33,153,323	78,153,323	RGD:61062	RGD
Q	Cia20	Collagen induced arthritis QTL 20			IED	10	24,006,429	160,657,542	RGD:631168	RGD
Q	Cia21	Collagen induced arthritis QTL 21			IED	10	14,721,135	159,833,317	RGD:631168	RGD
Q	Cia22	Collagen induced arthritis QTL 22			IED	10	41,339,689	152,260,081	RGD:631168	RGD
Q	Cia23	Collagen induced arthritis QTL 23			IED	10	41,339,689	152,260,081	RGD:631168	RGD
Q	Cia24	Collagen induced arthritis QTL 24			IED	4	149,304,432	179,854,843	RGD:61066	RGD
Q	Cia25	Collagen induced arthritis QTL 25			IED	12	20,932,555	36,894,750	RGD:1285224	RGD
Q	Cia26	Collagen induced arthritis QTL 26			IED	18	57,870,442	87,265,094	RGD:1285224	RGD
Q	Cia27	Collagen induced arthritis QTL 27			IAGP	10	95,695,048	111,406,914	RGD:61063	RGD
Q	Cia3	Collagen induced arthritis QTL 3			IED	4	104,415,843	149,415,843	RGD:61062	RGD
Q	Cia4	Collagen induced arthritis QTL 4			IED	7	62,224,456	66,202,126	RGD:61062	RGD
Q	Cia4	Collagen induced arthritis QTL 4			IED	7	62,224,456	66,202,126	RGD:61069	RGD
Q	Cia5	Collagen induced arthritis QTL 5			IED	10	95,692,240	140,692,240	RGD:61062	RGD
Q	Cia6	Collagen induced arthritis QTL 6			IED	8	86,627,869	127,907,359	RGD:61067	RGD
Q	Cia7	Collagen induced arthritis QTL 7			IED	2	59,700,886	146,659,672	RGD:61067	RGD
Q	Cia7	Collagen induced arthritis QTL 7			IED	2	59,700,886	146,659,672	RGD:61063	RGD
Q	Cia8	Collagen induced arthritis QTL 8			IED				RGD:61069	RGD
Q	Cia9	Collagen induced arthritis QTL 9			IED				RGD:61063	RGD
Q	Ciaa1	CIA Autoantibody QTL 1			IED	20	2,790,511	4,530,895	RGD:61066	RGD
Q	Ciaa1	CIA Autoantibody QTL 1			IED	20	2,790,511	4,530,895	RGD:61062	RGD
Q	Ciaa2	CIA Autoantibody QTL 2			IED	10	64,308,668	95,695,218	RGD:61066	RGD
Q	Ciaa2	CIA Autoantibody QTL 2			IED	10	64,308,668	95,695,218	RGD:61518	RGD
Q	Ciaa4	CIA Autoantibody QTL 4			IED	4	128,179,957	171,204,531	RGD:61067	RGD
Q	Ciaa5	CIA Autoantibody QTL 5			IED	5	99,080,786	149,757,440	RGD:61067	RGD
Q	Oia7	Oil induced arthritis QTL 7			IED	4	159,298,584	160,528,447	RGD:730281	RGD
Q	Oia8	Oil induced arthritis QTL 8			IED	4	136,668,162	181,668,162	RGD:629560	RGD
Q	Pia10	Pristane induced arthritis QTL 10			IED	10	24,006,429	160,657,542	RGD:61519	RGD
Q	Pia11	Pristane induced arthritis QTL 11			IED	1	83,489,176	186,472,032	RGD:631225	RGD
Q	Pia12	Pristane induced arthritis QTL 12			IED	12	555,108	24,748,499	RGD:631225	RGD
Q	Pia13	Pristane induced arthritis QTL 13			IED	14	43,399,833	105,009,429	RGD:631225	RGD
Q	Pia14	Pristane induced arthritis QTL 14			IED	16	59,398,206	88,891,349	RGD:631225	RGD
Q	Pia15	Pristane induced arthritis QTL 15			IED	10	24,731,630	47,777,990	RGD:631850	RGD
Q	Pia16	Pristane induced arthritis QTL 16			IED	6	47,039,212	108,621,490	RGD:631850	RGD
Q	Pia17	Pristane induced arthritis QTL 17			IED	7	78,497,123	137,838,800	RGD:631850	RGD
Q	Pia18	Pristane induced arthritis QTL 18			IED	8	79,347,688	87,122,814	RGD:631850	RGD
Q	Pia19	Pristane induced arthritis QTL 19			IED	18	77,452,390	82,920,522	RGD:631850	RGD
Q	Pia20	Pristane induced arthritis QTL 20			IED	14	10,340,377	41,608,939	RGD:730280	RGD
Q	Pia21	Pristane induced arthritis QTL 21			IAGP	20	3,660,646	4,740,814	RGD:631850	RGD
Q	Pia22	Pristane induced arthritis QTL 22			IED	12	530,865	45,530,865	RGD:629560	RGD
Q	Pia23	Pristane induced arthritis QTL 23			IAGP	4	133,939,407	171,204,531	RGD:631850	RGD
Q	Pia24	Pristane induced arthritis QTL 24			IED	6	117,361,909	147,636,619	RGD:728382	RGD
Q	Pia26	Pristane induced arthritis QTL 26			IAGP	10	35,131,252	76,591,208	RGD:1358860	RGD
Q	Pia27	Pristane induced arthritis QTL 27		No_Association	IAGP	11	84,560,085	85,432,136	RGD:2302026	RGD
Q	Pia28	Pristane induced arthritis QTL 28			IAGP	4	74,123,346	119,123,346	RGD:2302026	RGD
Q	Pia29	Pristane induced arthritis QTL 29		No_Association	IAGP	16	24,934,312	69,934,312	RGD:2302026	RGD
Q	Pia30	Pristane induced arthritis QTL 30			IAGP	3	25,222,506	70,222,506	RGD:2302026	RGD
Q	Pia31	Pristane induced arthritis QTL 31			IAGP	17	1	26,143,121	RGD:2302026	RGD
Q	Pia32	Pristane induced arthritis QTL 32			IAGP	4	107,728,559	152,728,559	RGD:2302026	RGD
Q	Pia33	Pristane induced arthritis QTL 33			IAGP	5	1	40,017,184	RGD:2302026	RGD
Q	Pia34	Pristane induced arthritis QTL 34			IAGP				RGD:2302026	RGD
Q	Pia35	Pristane induced arthritis QTL 35			IAGP				RGD:2302026	RGD
Q	Pia36	Pristane induced arthritis QTL 36			IAGP	1	41,645,883	86,645,883	RGD:2302026	RGD
Q	Pia37	Pristane induced arthritis QTL 37			IAGP	12	14,334,630	46,782,294	RGD:2302026	RGD
Q	Pia38	Pristane induced arthritis QTL 38			IAGP	12	568,621	45,568,621	RGD:2302026	RGD
Q	Pia39	Pristane induced arthritis QTL 39			IAGP	14	10,539,919	55,539,919	RGD:2302026	RGD
Q	Pia40	Pristane induced arthritis QTL 40		Induced	IED	20	1,616,449	5,447,380	RGD:2306838	RGD
Q	Pia41	Pristane induced arthritis QTL 41			IAGP	1	183,163,129	185,328,208	RGD:6892695	RGD
Q	Pia42	Pristane induced arthritis QTL 42		Induced	IED	12	20,932,559	43,863,270	RGD:1600250	RGD
Q	Pia7	Pristane induced arthritis QTL 7			IED	4	133,939,407	171,204,531	RGD:629560	RGD
Q	Pia8	Pristane induced arthritis QTL 8			IED	1	1,595,127	64,145,956	RGD:629570	RGD
Q	Pia9	Pristane induced arthritis QTL 9			IAGP	4	81,916,057	126,916,057	RGD:629560	RGD
Q	Scwia1	Streptococcal cell wall induced arthritis QTL 1			IED	4	73,972,453	154,937,227	RGD:61064	RGD
S	BBDR/WorN			Model	TAS				RGD:1578691	RGD
S	DA	DA			TAS				RGD:1004	RGD
S	DA.ACI-(D12Wox12-D12Rat53)/Arb			Induced	IED	12	20,932,555	43,863,270	RGD:1600250	RGD
S	DA.ACI-(D2Mit12-D2Mgh29)/Nsi				IED	2	174,730,375	227,310,008	RGD:1358860	RGD
S	DA.E3-(D11Got79-D11Rat50)/Rhd			No_Association	IED	11	82,238,710	84,841,212	RGD:2302066	RGD
S	DA.E3-(D11Got79-D11Wox5)/Rhd			No_Association	IED	11	82,238,710	85,432,136	RGD:2302066	RGD
S	DA.E3-(D12Got46-D12Rat26)/Rhd			Resistance	IDA	12	23,362,298	23,845,733	RGD:1625013	RGD
S	DA.E3-(D4Wox49-D4Got136)/Rhd			Resistance	IED	4	159,060,677	160,528,447	RGD:2324629	RGD
S	DA.F344-(D10Rat24-D10Rat11)/Nsi			Induced	IED	10	69,160,380	106,310,957	RGD:1359065	RGD
S	DA.F344-(D10Rat37-D10Arb9)/Nsi			Induced	TAS	10	31,931,622	79,229,233	RGD:1599708	RGD
S	DA.F344-(D10Rat37-D10Wox22)/Nsi			Induced	IED	10	31,931,622	100,633,982	RGD:1359065	RGD
S	DA.F344-(D20Arb2-D20Arb8)/Arb			Induced	IED	20	2,790,511	2,811,567	RGD:629569	RGD
S	DA.F344-Aia1/1				QTM	20	2,790,511	32,560,683	RGD:625379	RGD
S	DA.F344-Aia1/2				QTM	4	36,592,628	85,014,222	RGD:625379	RGD
S	DA.F344-Aia1/3				QTM	4	54,879,077	54,879,214	RGD:625379	RGD
S	DA.F344-Aia1/4				QTM	10	24,006,429	24,006,612	RGD:625379	RGD
S	DA/Bkl				IED				RGD:61066	RGD
S	DA/ZtmRhd			Susceptibility	IAGP				RGD:2302026	RGD
S	E3.DA-(D12Wox5-D12Rat26)/Rhd			Resistance	IED	12	23,845,554	23,845,733	RGD:2306838	RGD
S	E3.DA-(D20Rat45-D20Rat47)/Rhd			Induced	IED	6 20	133,455,626 1,616,332	133,455,718 5,447,494	RGD:2306838	RGD
S	E3.DA-(D4Wox22-D4Got132)(D12Wox5-D12Rat26)/Rhd			Susceptibility	IED				RGD:2306838	RGD
S	E3/ZtmRhd			Resistance	IAGP				RGD:2302026	RGD
S	LEW.1AV1.DA-(D10Got154-D10Rat135)/Ubc				QTM	10	101,532,360	108,776,963	RGD:62404	RGD
S	LEW.1AV1.DA-(D10Rat92-D10Rat135)/Ubc				QTM	10	78,170,416	108,776,963	RGD:61087	RGD
S	LEW.1AV1.DA-(D10Rat92-D10Wox17)/Ubc				QTM	10	78,170,416	91,168,491	RGD:62404	RGD
S	LEW.1AV1.DA-(D10Wox17-D10Rat135)/Ubc				QTM	10	91,168,332	108,776,963	RGD:62404	RGD
S	LEW.1F				QTM				RGD:631225	RGD
S	PVG.LEW-(D1Rat270-D1Rat68)/Kini				IAGP	1	130,290,073	193,070,197	RGD:6892695	RGD
S	Rhd:F344,GK-G21			No_Association	IED				RGD:2302066	RGD
Arthrogryposis
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Myh8	myosin, heavy chain 8, skeletal muscle, perinatal			ISS	10	53,973,711	54,002,442	RGD:1600548	RGD
G	Tnni2	troponin I type 2 (skeletal, fast)			ISS	1	202,687,630	202,690,172	RGD:1599481	RGD
G	Tnnt3	troponin T type 3 (skeletal, fast)			ISS	1	202,748,063	202,761,965	RGD:1599490	RGD
G	Vps33b	vacuolar protein sorting 33 homolog B (yeast)			ISS	1	136,085,931	136,109,421	RGD:1599749	RGD
Arthrogryposis multiplex congenita, distal, X-linked
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Uba1	ubiquitin-like modifier activating enzyme 1			ISS	X	12,926,049	12,944,522	RGD:7240710	OMIM
Arthrogryposis renal dysfunction cholestasis syndrome
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Vps33b	vacuolar protein sorting 33 homolog B (yeast)			ISS	1	136,085,931	136,109,421	RGD:7240710	OMIM
ARTHROGRYPOSIS, DISTAL, TYPE 1A
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Tpm2	tropomyosin 2, beta			ISS	5	59,994,101	60,003,261	RGD:7240710	OMIM
Arthropathy, progressive pseudorheumatoid, of childhood
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Wisp3	WNT1 inducible signaling pathway protein 3			ISS	20	43,297,076	43,312,790	RGD:7240710	OMIM
ATELOSTEOGENESIS, TYPE III
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Flnb	filamin B, beta			ISS	15	18,949,027	19,082,504	RGD:7240710	OMIM
G	Sct	secretin			ISS	1	201,472,250	201,472,944	RGD:7240710	OMIM
AXENFELD-RIEGER SYNDROME, TYPE 1
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Pitx2	paired-like homeodomain 2			ISS	2	226,581,170	226,601,319	RGD:7240710	OMIM
Bamforth syndrome
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Foxe1	forkhead box E1 (thyroid transcription factor 2)			ISS	5	62,905,210	62,908,018	RGD:7240710	OMIM
BAND-LIKE CALCIFICATION WITH SIMPLIFIED GYRATION AND POLYMICROGYRIA
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Ocln	occludin			ISS	2	31,317,090	31,367,485	RGD:7240710	OMIM
Bethlem myopathy
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Col6a1	collagen, type VI, alpha 1			ISS	20	12,320,102	12,338,500	RGD:7240710	OMIM
G	Col6a2	collagen, type VI, alpha 2			ISS	20	12,436,783	12,464,512	RGD:7240710	OMIM
G	Col6a3	collagen, type VI, alpha 3			ISS	9	89,990,129	90,043,697	RGD:7240710	OMIM
Birk-Barel Mental Retardation Dysmorphism Syndrome
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Kcnk9	potassium channel, subfamily K, member 9			ISS	7	110,232,743	110,267,546	RGD:7240710	OMIM
Bohring syndrome
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Asxl1	additional sex combs like 1			ISS	3	143,703,295	143,767,523	RGD:7240710	OMIM
Bone Fragility with Contractures, Arterial Rupture, and Deafness
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Plod3	procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3			ISS	12	20,856,527	20,867,088	RGD:7240710	OMIM
Brachydactyly type A1
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Ihh	Indian hedgehog			ISS	9	74,287,115	74,293,332	RGD:7240710	OMIM
Brachydactyly type A2
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Bmp2	bone morphogenetic protein 2			ISS	3	121,372,692	121,381,236	RGD:7240710	OMIM
G	Bmpr1b	bone morphogenetic protein receptor, type IB			ISS	2	239,727,569	239,767,802	RGD:7240710	OMIM
G	Gdf5	growth differentiation factor 5			ISS				RGD:7240710	OMIM
Brachydactyly type C
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Gdf5	growth differentiation factor 5			ISS				RGD:7240710	OMIM
Brachydactyly, Type B1
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Ror2	receptor tyrosine kinase-like orphan receptor 2			ISS	17	17,735,999	17,917,032	RGD:7240710	OMIM
Brachydactyly, Type B2
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Nog	noggin			ISS	10	77,689,244	77,690,871	RGD:7240710	OMIM
Brachydactyly, Type D
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Hoxd13	homeo box D13			ISS	3	57,283,682	57,286,998	RGD:7240710	OMIM
BRACHYDACTYLY, TYPE E1
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Hoxd13	homeo box D13			ISS	3	57,283,682	57,286,998	RGD:7240710	OMIM
BRACHYDACTYLY, TYPE E2
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Pthlh	parathyroid hormone-like hormone			ISS	4	184,887,702	184,898,841	RGD:7240710	OMIM
Brachydactyly-Syndactyly Syndrome
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Hoxd13	homeo box D13			ISS	3	57,283,682	57,286,998	RGD:7240710	OMIM
Brody myopathy
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Atp2a1	ATPase, Ca++ transporting, cardiac muscle, fast twitch 1			ISS				RGD:7240710	OMIM
Bruck syndrome 2
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Plod2	procollagen lysine, 2-oxoglutarate 5-dioxygenase 2			ISS	8	97,525,279	97,623,152	RGD:7240710	OMIM
C SYNDROME
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Cd96	CD96 molecule			ISS	11	56,183,593	56,258,568	RGD:7240710	OMIM
Campomelic Dysplasia
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Sox9	SRY (sex determining region Y)-box 9			ISS	10	102,392,187	102,394,256	RGD:7240710	OMIM
G	Sra1	steroid receptor RNA activator 1			ISS	18	29,306,555	29,309,783	RGD:7240710	OMIM
Carnitine Palmitoyltransferase II Deficiency, Late-Onset
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Cpt2	carnitine palmitoyltransferase 2			ISS	5	129,007,685	129,025,501	RGD:7240710	OMIM
CATSHL syndrome
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Fgfr3	fibroblast growth factor receptor 3			ISS	14	82,683,191	82,697,229	RGD:7240710	OMIM
Cerebral Cavernous Malformations 2
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Ccm2	cerebral cavernous malformation 2			ISS	14	87,307,223	87,353,553	RGD:7240710	OMIM
Cerebral Cavernous Malformations 3
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Pdcd10	programmed cell death 10			ISS	2	166,402,652	166,445,015	RGD:7240710	OMIM
Cerebrooculofacioskeletal Syndrome 2
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Ercc2	excision repair cross-complementing rodent repair deficiency, complementation group 2			ISS				RGD:7240710	OMIM
Cerebrooculofacioskeletal Syndrome 4
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Ercc1	excision repair cross-complementing rodent repair deficiency, complementation group 1			ISS	1	78,711,249	78,722,474	RGD:7240710	OMIM
Cherubism
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Sh3bp2	SH3-domain binding protein 2			ISS	14	81,818,728	81,855,875	RGD:1599339	RGD
G	Sh3bp2	SH3-domain binding protein 2			ISS	14	81,818,728	81,855,875	RGD:7240710	OMIM
Chondrocalcinosis
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Ankh	ankylosis, progressive homolog (mouse)			ISS	2	79,289,427	79,418,518	RGD:734570	RGD
G	Ankh	ankylosis, progressive homolog (mouse)			ISS	2	79,289,427	79,418,518	RGD:7240710	OMIM
Chondrocalcinosis 2
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Ankh	ankylosis, progressive homolog (mouse)			ISS	2	79,289,427	79,418,518	RGD:7240710	OMIM
Chondrodysplasia, acromesomelic, with genital anomalies
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Bmpr1b	bone morphogenetic protein receptor, type IB			ISS	2	239,727,569	239,767,802	RGD:7240710	OMIM
Chondrodysplasia, Grebe type
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Gdf5	growth differentiation factor 5			ISS				RGD:7240710	OMIM
CK SYNDROME
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Nsdhl	NAD(P) dependent steroid dehydrogenase-like			ISS	X	158,923,025	158,954,914	RGD:7240710	OMIM
Cleft Palate
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Cbfb	core-binding factor, beta subunit			ISS	19	34,985,879	35,029,446	RGD:7240710	OMIM
G	Irf6	interferon regulatory factor 6			ISS	13	108,986,973	109,006,180	RGD:1600214	RGD
G	Msx1	msh homeobox 1			ISS	14	78,257,345	78,261,144	RGD:5132609	RGD
G	Pvrl1	poliovirus receptor-related 1			ISS	8	46,739,657	46,799,051	RGD:1599795	RGD
G	Tbx22	T-box 22			ISS	X	95,912,796	95,926,843	RGD:724722	RGD
Cleft palate X-linked
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Tbx22	T-box 22			ISS	X	95,912,796	95,926,843	RGD:7240710	OMIM
Cleft Palate, Isolated, And Mental Retardation
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Satb2	SATB homeobox 2			ISS	9	55,647,221	55,824,683	RGD:7240710	OMIM
G	Ubb	ubiquitin B			ISS	10	139,578,694	139,579,068	RGD:7240710	OMIM
Cleidocranial Dysplasia
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Runx2	runt-related transcription factor 2			ISS	9	11,869,234	12,025,219	RGD:1601649	RGD
G	Runx2	runt-related transcription factor 2			ISS	9	11,869,234	12,025,219	RGD:7240710	OMIM
Clubfoot
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Pitx1	paired-like homeodomain 1			ISS	17	14,834,144	14,840,303	RGD:7240710	OMIM
S	WCF				TAS				RGD:1004	RGD
COCOON SYNDROME
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Chuk	conserved helix-loop-helix ubiquitous kinase			ISS	1	249,122,845	249,158,369	RGD:7240710	OMIM
COENZYME Q10 DEFICIENCY, PRIMARY, 1
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Coq2	coenzyme Q2 homolog, prenyltransferase (yeast)			ISS	14	10,189,565	10,208,996	RGD:7240710	OMIM
Combined Oxidative Phosphorylation Deficiency 2
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Mrps16	mitochondrial ribosomal protein S16			ISS	15	4,147,260	4,149,662	RGD:7240710	OMIM
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Aifm1	apoptosis-inducing factor, mitochondrion-associated 1			ISS	X	134,868,878	134,908,166	RGD:7240710	OMIM
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	RGD1563482	similar to hypothetical protein FLJ38663			ISS	12	33,377,684	33,391,371	RGD:7240710	OMIM
Congenital Cataracts, Facial Dysmorphism, And Neuropathy
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Ctdp1	CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) phosphatase, subunit 1			ISS	18	77,304,752	77,365,895	RGD:7240710	OMIM
Congenital contractural arachnodactyly
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Fbn2	fibrillin 2			ISS	18	53,883,011	53,914,001	RGD:7240710	OMIM
Congenital Hemidysplasia with Ichthyosiform Erythroderma and Limb Defects
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Nsdhl	NAD(P) dependent steroid dehydrogenase-like			ISS	X	158,923,025	158,954,914	RGD:7240710	OMIM
Corpus Callosum, Agenesis of, with Mental Retardation, Ocular Coloboma, and Micrognathia
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Igbp1	immunoglobulin (CD79A) binding protein 1			ISS	X	88,490,498	88,507,054	RGD:7240710	OMIM
Costello Syndrome
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Hras	Harvey rat sarcoma virus oncogene			ISS	1	201,385,705	201,388,987	RGD:7240710	OMIM
Cranioectodermal Dysplasia
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Ift122	intraflagellar transport 122 homolog (Chlamydomonas)			ISS	4	151,982,026	152,052,635	RGD:7240710	OMIM
CRANIOECTODERMAL DYSPLASIA 2
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Wdr35	WD repeat domain 35			ISS	6	32,522,578	32,523,842	RGD:7240710	OMIM
Craniofacial Abnormalities
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Acox2	acyl-CoA oxidase 2, branched chain			ISS	15	18,645,349	18,677,855	RGD:1300345	RGD
G	Ece1	endothelin converting enzyme 1			ISS	5	156,635,656	156,735,783	RGD:734910	RGD
G	Ercc2	excision repair cross-complementing rodent repair deficiency, complementation group 2			ISS				RGD:1601070	RGD
G	Gnaq	guanine nucleotide binding protein (G protein), q polypeptide			ISS	1	219,520,998	219,764,401	RGD:737757	RGD
G	Msx2	msh homeobox 2			ISS	17	17,243,262	17,248,927	RGD:1600492	RGD
G	Pqbp1	polyglutamine binding protein 1			ISS	X	26,638,460	26,642,640	RGD:7240710	OMIM
G	Pten	phosphatase and tensin homolog			ISS	1	236,771,027	236,837,261	RGD:7240710	OMIM
G	Ptpn11	protein tyrosine phosphatase, non-receptor type 11			ISS	12	36,501,886	36,558,055	RGD:1601571	RGD
G	Vsx1	visual system homeobox 1			ISS	3	141,322,816	141,330,415	RGD:7240710	OMIM
Craniofacial deafness hand syndrome
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Pax3	paired box 3			ISS	9	77,477,813	77,576,632	RGD:7240710	OMIM
Craniofacial Dysostosis
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Fgfr2	fibroblast growth factor receptor 2			ISS	1	189,482,975	189,589,279	RGD:7240710	OMIM
Craniofrontonasal dysplasia
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Efnb1	ephrin B1			ISS	X	87,163,176	87,175,982	RGD:7240710	OMIM
Craniolenticulosutural Dysplasia
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Sec23a	Sec23 homolog A (S. cerevisiae)			ISS	6	79,660,575	79,706,898	RGD:7240710	OMIM
Craniometaphyseal Dysplasia, Autosomal Dominant
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Ankh	ankylosis, progressive homolog (mouse)			ISS	2	79,289,427	79,418,518	RGD:7240710	OMIM
Craniosynostoses
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Fbn1	fibrillin 1			ISS	3	112,608,480	112,804,118	RGD:1601145	RGD
G	Fgfr2	fibroblast growth factor receptor 2			ISS	1	189,482,975	189,589,279	RGD:6480630	RGD
G	Fgfr2	fibroblast growth factor receptor 2			ISS	1	189,482,975	189,589,279	RGD:6480631	RGD
G	Msx2	msh homeobox 2			ISS	17	17,243,262	17,248,927	RGD:1600491	RGD
G	Nell1	NEL-like 1 (chicken)			IPM	1	99,805,922	100,758,002	RGD:633405	RGD
Craniosynostosis radial aplasia syndrome
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Recql4	RecQ protein-like 4			ISS	7	114,752,863	114,760,027	RGD:7240710	OMIM
Craniosynostosis, Type 2
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Msx2	msh homeobox 2			ISS	17	17,243,262	17,248,927	RGD:7240710	OMIM
Crisponi syndrome
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Crlf1	cytokine receptor-like factor 1			ISS	16	19,431,472	19,442,747	RGD:7240710	OMIM
Crouzon Syndrome With Acanthosis Nigricans
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Fgfr3	fibroblast growth factor receptor 3			ISS	14	82,683,191	82,697,229	RGD:7240710	OMIM
Cutis Gyrata Syndrome of Beare And Stevenson
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Fgfr2	fibroblast growth factor receptor 2			ISS	1	189,482,975	189,589,279	RGD:7240710	OMIM
Dermatomyositis
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Cd36	CD36 molecule (thrombospondin receptor)			ISS	4	13,471,878	13,525,620	RGD:6893508	RGD
G	Il18	interleukin 18			ISS	8	53,936,584	53,943,228	RGD:4889547	RGD
G	Pms1	postmeiotic segregation increased 1 (S. cerevisiae)			ISS	9	45,203,344	45,292,624	RGD:2324870	RGD
G	Thbd	thrombomodulin			ISS	3	137,158,955	137,162,607	RGD:5685006	RGD
Desbuquois syndrome
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Cant1	calcium activated nucleotidase 1			ISS	10	108,405,355	108,420,225	RGD:7240710	OMIM
DiGeorge Syndrome
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Aldh1a2	aldehyde dehydrogenase 1 family, member A2			ISS	8	75,692,099	75,771,159	RGD:734550	RGD
G	Arvcf	armadillo repeat gene deleted in velo-cardio-facial syndrome			ISS	11	84,582,208	84,639,874	RGD:1578806	RGD
G	Comt	catechol-O-methyltransferase			ISS	11	84,561,591	84,581,713	RGD:7240710	OMIM
G	Dvl1	dishevelled, dsh homolog 1 (Drosophila)			ISS	5	172,705,951	172,717,626	RGD:1580898	RGD
G	Tbx1	T-box 1			ISS	11	84,400,980	84,410,631	RGD:7240710	OMIM
G	Tssk2	testis-specific serine kinase 2			ISS	11	85,074,711	85,076,066	RGD:1580778	RGD
G	Ufd1l	ubiquitin fusion degradation 1 like (yeast)			ISS				RGD:1580803	RGD
G	Usp18	ubiquitin specific peptidase 18			ISS	4	157,692,720	157,694,884	RGD:1549873	RGD
Dimauro disease
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Pgam2	phosphoglycerate mutase 2 (muscle)			ISS	14	86,466,055	86,468,166	RGD:7240710	OMIM
DISORDERED STEROIDOGENESIS DUE TO CYTOCHROME P450 OXIDOREDUCTASE DEFICIENCY
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Por	P450 (cytochrome) oxidoreductase			ISS	12	22,078,629	22,097,301	RGD:7240710	OMIM
Distal arthrogryposis type 2B
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Myh3	myosin, heavy chain 3, skeletal muscle, embryonic			ISS	10	53,776,858	53,800,677	RGD:7240710	OMIM
G	Tnni2	troponin I type 2 (skeletal, fast)			ISS	1	202,687,630	202,690,172	RGD:7240710	OMIM
G	Tnnt3	troponin T type 3 (skeletal, fast)			ISS	1	202,748,063	202,761,965	RGD:7240710	OMIM
G	Tpm2	tropomyosin 2, beta			ISS	5	59,994,101	60,003,261	RGD:7240710	OMIM
Distal Myopathies
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Matr3	matrin 3			ISS	18	28,171,639	28,215,659	RGD:7240710	OMIM
G	Myh7	myosin, heavy chain 7, cardiac muscle, beta			ISS	15	33,072,928	33,094,595	RGD:7240710	OMIM
Distal myopathy Markesbery-Griggs type
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Ttn	titin			ISS	3	59,404,023	59,665,308	RGD:7240710	OMIM
Distal myopathy, Nonaka type
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Gne	glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase			ISS	5	60,506,171	60,536,403	RGD:7240710	OMIM
Donohue Syndrome
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Insr	insulin receptor			ISS	12	2,934,967	3,087,691	RGD:7240710	OMIM
Dysgnathia complex
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Prrx1	paired related homeobox 1			ISS	13	78,961,648	79,028,882	RGD:7240710	OMIM
Dystrophia myotonica 1
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Dmpk	dystrophia myotonica-protein kinase			ISS	1	78,449,324	78,450,578	RGD:7240710	OMIM
Ectodermal dysplasia, ectrodactyly, and macular dystrophy
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Cdh3	cadherin 3			ISS	19	36,343,823	36,393,819	RGD:7240710	OMIM
ECTODERMAL DYSPLASIA-SYNDACTYLY SYNDROME 1
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Pvrl4	poliovirus receptor-related 4			ISS	13	87,275,975	87,294,493	RGD:7240710	OMIM
Ectrodactyly, Ectodermal Dysplasia, and Cleft Lip/Palate Syndrome 3
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Tp63	tumor protein p63			ISS	11	76,900,622	77,200,251	RGD:7240710	OMIM
Ectromelia
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Wnt3	wingless-type MMTV integration site family, member 3			ISS	10	92,925,605	92,969,613	RGD:1599852	RGD
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Chst14	carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 14			ISS	3	105,439,600	105,441,657	RGD:7240710	OMIM
Epidermolysa bullosa simplex and limb girdle muscular dystrophy
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Plec	plectin			ISS	7	114,202,742	114,262,385	RGD:7240710	OMIM
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 10
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Pnkp	polynucleotide kinase 3'-phosphatase			ISS	1	95,330,455	95,335,468	RGD:7240710	OMIM
Erythrocyte Lactate Transporter Defect
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Slc16a1	solute carrier family 16, member 1 (monocarboxylic acid transporter 1)			ISS	2	199,860,341	199,879,856	RGD:7240710	OMIM
Exocrine Pancreatic Insufficiency, Dyserythropoietic Anemia, and Calvarial Hyperostosis
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Cox4i2	cytochrome c oxidase subunit IV isoform 2 (lung)			ISS	3	143,103,348	143,114,236	RGD:7240710	OMIM
Fairbank disease
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Comp	cartilage oligomeric matrix protein			ISS				RGD:7240710	OMIM
Fatigue Syndrome, Chronic
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Cd28	Cd28 molecule			ISS	9	59,342,273	59,367,743	RGD:5131614	RGD
G	Disc1	disrupted in schizophrenia 1		Susceptibility	ISS	19	55,265,116	55,449,375	RGD:5509831	RGD
G	Prf1	perforin 1 (pore forming protein)			ISS	20	28,658,367	28,663,877	RGD:6482801	RGD
G	Ren	renin			ISS	13	46,262,936	46,275,213	RGD:6892702	RGD
G	RT1-Ba	RT1 class II, locus Ba			ISS	20	4,697,971	4,702,564	RGD:5147827	RGD
FIBULAR APLASIA OR HYPOPLASIA, FEMORAL BOWING AND POLY-, SYN-, AND OLIGODACTYLY
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Wnt7a	wingless-type MMTV integration site family, member 7A			ISS	4	125,541,281	125,586,167	RGD:7240710	OMIM
Fibular hypoplasia and complex brachydactyly
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Gdf5	growth differentiation factor 5			ISS				RGD:7240710	OMIM
Filaminopathy, autosomal dominant
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Flnc	filamin C, gamma			ISS	4	56,313,707	56,341,400	RGD:7240710	OMIM
Foot Deformities, Congenital
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Hoxd10	homeo box D10			ISS	3	57,306,064	57,309,273	RGD:7240710	OMIM
FRAGILE X MENTAL RETARDATION SYNDROME
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Fmr1	fragile X mental retardation 1			ISS	X	154,756,031	154,793,782	RGD:7240710	OMIM
Freeman-Sheldon syndrome
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Myh3	myosin, heavy chain 3, skeletal muscle, embryonic			ISS	10	53,776,858	53,800,677	RGD:7240710	OMIM
FRONTONASAL DYSPLASIA 1
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Alx3	ALX homeobox 3			ISS	2	203,156,009	203,157,503	RGD:7240710	OMIM
FRONTONASAL DYSPLASIA 2
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Alx4	ALX homeobox 4			ISS	3	78,057,714	78,094,285	RGD:7240710	OMIM
FRONTONASAL DYSPLASIA 3
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Alx1	ALX homeobox 1			ISS	7	41,090,481	41,110,281	RGD:7240710	OMIM
Gastroschisis
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Add1	adducin 1 (alpha)			ISS	14	81,750,430	81,808,919	RGD:5148000	RGD
G	Nos2	nitric oxide synthase 2, inducible			IEP	10	65,036,884	65,072,453	RGD:5508749	RGD
Gaze Palsy, Familial Horizontal, with Progressive Scoliosis
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Robo3	roundabout, axon guidance receptor, homolog 3 (Drosophila)			ISS	8	38,668,913	38,683,439	RGD:7240710	OMIM
GELEOPHYSIC DYSPLASIA 1
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Adamtsl2	ADAMTS-like 2			ISS	3	5,976,490	6,004,532	RGD:7240710	OMIM
Glycogen Storage Disease Type VII
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Pfkm	phosphofructokinase, muscle			ISS	7	136,826,122	136,846,040	RGD:1599108	RGD
G	Pfkm	phosphofructokinase, muscle			ISS	7	136,826,122	136,846,040	RGD:7240710	OMIM
Goldberg-Shprintzen megacolon syndrome
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	LOC606294	hypothetical protein LOC606294			ISS	20	29,817,255	29,836,819	RGD:7240710	OMIM
Greig cephalopolysyndactyly syndrome
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Gli3	GLI family zinc finger 3			ISS	17	57,594,102	57,867,710	RGD:7240710	OMIM
Hallermann's Syndrome
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Gja1	gap junction protein, alpha 1			ISS	20	35,409,815	35,422,262	RGD:7240710	OMIM
Hand Deformities, Congenital
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Gdf5	growth differentiation factor 5			ISS				RGD:704404	RGD
G	Ihh	Indian hedgehog			ISS	9	74,287,115	74,293,332	RGD:1600032	RGD
Hand foot uterus syndrome
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Hoxa13	homeo box A13			ISS	4	80,558,841	80,561,053	RGD:7240710	OMIM
Hay-Wells syndrome
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Tp63	tumor protein p63			ISS	11	76,900,622	77,200,251	RGD:7240710	OMIM
Heart-hand syndrome, Slovenian type
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Lmna	lamin A/C			ISS	2	180,595,724	180,616,354	RGD:7240710	OMIM
Hecht syndrome
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Myh8	myosin, heavy chain 8, skeletal muscle, perinatal			ISS	10	53,973,711	54,002,442	RGD:7240710	OMIM
Hennekam lymphangiectasia lymphedema syndrome
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Ccbe1	collagen and calcium binding EGF domains 1			ISS	18	62,407,265	62,442,194	RGD:7240710	OMIM
Hereditary Myopathy with Early Respiratory Failure
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Ttn	titin			ISS	3	59,404,023	59,665,308	RGD:7240710	OMIM
Histiocytosis with joint contractures and sensorineural deafness
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Slc29a3	solute carrier family 29 (nucleoside transporters), member 3			ISS	20	28,041,914	28,080,232	RGD:7240710	OMIM
Holoprosencephaly
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Gli2	GLI family zinc finger 2			ISS	13	31,551,089	31,607,264	RGD:7240710	OMIM
G	Ptch1	patched 1			ISS	17	7,088,234	7,142,459	RGD:7240710	OMIM
G	Shh	sonic hedgehog			ISS	4	2,200,504	2,209,657	RGD:1580354	RGD
G	Shh	sonic hedgehog			ISS	4	2,200,504	2,209,657	RGD:7240710	OMIM
G	Six3	SIX homeobox 3			ISS	6	8,981,995	9,019,365	RGD:1599336	RGD
G	Six3	SIX homeobox 3			ISS	6	8,981,995	9,019,365	RGD:1599335	RGD
G	Six3	SIX homeobox 3			ISS	6	8,981,995	9,019,365	RGD:7240710	OMIM
G	Tdgf1	teratocarcinoma-derived growth factor 1			ISS	8	115,341,587	115,346,871	RGD:7240710	OMIM
G	Tgif1	TGFB-induced factor homeobox 1			ISS	9	110,043,164	110,052,783	RGD:1599407	RGD
G	Zic2	Zic family member 2			ISS	15	107,609,060	107,613,169	RGD:7240710	OMIM
Holoprosencephaly 2
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Six3	SIX homeobox 3			ISS	6	8,981,995	9,019,365	RGD:7240710	OMIM
Holoprosencephaly 3
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Shh	sonic hedgehog			ISS	4	2,200,504	2,209,657	RGD:7240710	OMIM
Holoprosencephaly 5
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Zic2	Zic family member 2			ISS	15	107,609,060	107,613,169	RGD:7240710	OMIM
Holoprosencephaly 7
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Ptch1	patched 1			ISS	17	7,088,234	7,142,459	RGD:7240710	OMIM
Holoprosencephaly 9
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Gli2	GLI family zinc finger 2			ISS	13	31,551,089	31,607,264	RGD:7240710	OMIM
Holt-Oram syndrome
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Tbx5	T-box 5			ISS	12	37,956,658	38,004,255	RGD:7240710	OMIM
Hydrolethalus Syndrome 1
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Hyls1	hydrolethalus syndrome 1			ISS	8	35,345,398	35,354,440	RGD:7240710	OMIM
Hyperexplexia hereditary
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Glra1	glycine receptor, alpha 1			ISS	10	40,922,867	41,021,767	RGD:7240710	OMIM
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 1
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Pigv	phosphatidylinositol glycan anchor biosynthesis, class V			ISS	5	151,404,858	151,416,748	RGD:7240710	OMIM
HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 1
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Hpgd	hydroxyprostaglandin dehydrogenase 15 (NAD)			ISS	16	37,419,901	37,457,896	RGD:7240710	OMIM
Hypochondroplasia
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Fgfr3	fibroblast growth factor receptor 3			ISS	14	82,683,191	82,697,229	RGD:7240710	OMIM
Hypokalemic Periodic Paralysis
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Cacna1s	calcium channel, voltage-dependent, L type, alpha 1S subunit			ISS				RGD:704404	RGD
G	Cacna1s	calcium channel, voltage-dependent, L type, alpha 1S subunit			ISS				RGD:1300372	RGD
G	Kcne3	potassium voltage-gated channel, Isk-related family, member 3			ISS	1	157,558,044	157,565,008	RGD:1600040	RGD
HYPOKALEMIC PERIODIC PARALYSIS, TYPE 1
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Cacna1s	calcium channel, voltage-dependent, L type, alpha 1S subunit			ISS				RGD:7240710	OMIM
Hypokalemic Periodic Paralysis, Type 2
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Scn4a	sodium channel, voltage-gated, type IV, alpha subunit			ISS	10	95,710,710	95,760,323	RGD:7240710	OMIM
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 1
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Dnmt3b	DNA (cytosine-5-)-methyltransferase 3 beta			ISS	3	144,030,737	144,069,265	RGD:7240710	OMIM
Inclusion body myopathy autosomal recessive
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Gne	glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase			ISS	5	60,506,171	60,536,403	RGD:7240710	OMIM
Inclusion Body Myopathy With Early-Onset Paget Disease And Frontotemporal Dementia
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Vcp	valosin-containing protein			ISS	5	59,472,100	59,491,508	RGD:7240710	OMIM
Inclusion body myopathy, autosomal dominant
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Myh2	myosin, heavy chain 2, skeletal muscle, adult			ISS	10	53,864,777	53,891,711	RGD:7240710	OMIM
Jackson-Weiss syndrome
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Fgfr1	Fibroblast growth factor receptor 1			ISS	16	70,869,974	70,910,045	RGD:7240710	OMIM
G	Fgfr2	fibroblast growth factor receptor 2			ISS	1	189,482,975	189,589,279	RGD:7240710	OMIM
Jacobs syndrome
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Prg4	proteoglycan 4			ISS	13	64,753,316	64,769,533	RGD:7240710	OMIM
Joint Diseases
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Tbx4	T-box 4		Susceptibility	ISS	10	74,136,416	74,166,080	RGD:1601422	RGD
G	Wisp3	WNT1 inducible signaling pathway protein 3			ISS	20	43,297,076	43,312,790	RGD:1599850	RGD
Kearns-Sayre Syndrome
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Ppargc1a	peroxisome proliferator-activated receptor gamma, coactivator 1 alpha			ISS	14	64,278,115	64,370,912	RGD:7241824	RGD
Keutel syndrome
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Mgp	matrix Gla protein			ISS	4	173,910,595	173,913,917	RGD:7240710	OMIM
Kleefstra Syndrome
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Ehmt1	euchromatic histone-lysine N-methyltransferase 1			ISS	3	3,074,136	3,169,921	RGD:7240710	OMIM
Klippel Feil syndrome dominant type
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Gdf6	growth differentiation factor 6			ISS	5	23,739,175	23,756,140	RGD:7240710	OMIM
Klippel Feil syndrome recessive type
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Meox1	mesenchyme homeobox 1			ISS	10	90,921,589	90,942,298	RGD:7240710	OMIM
KLIPPEL-FEIL SYNDROME 3, AUTOSOMAL DOMINANT
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Gdf3	growth differentiation factor 3			ISS	4	159,064,054	159,067,854	RGD:7240710	OMIM
Kniest dysplasia
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Col2a1	collagen, type II, alpha 1			ISS	7	136,679,219	136,707,976	RGD:7240710	OMIM
Lacrimoauriculodentodigital syndrome
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Fgf10	fibroblast growth factor 10			ISS	2	50,866,799	50,940,319	RGD:7240710	OMIM
G	Fgfr2	fibroblast growth factor receptor 2			ISS	1	189,482,975	189,589,279	RGD:7240710	OMIM
G	Fgfr3	fibroblast growth factor receptor 3			ISS	14	82,683,191	82,697,229	RGD:7240710	OMIM
Larsen syndrome, dominant type
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Flnb	filamin B, beta			ISS	15	18,949,027	19,082,504	RGD:7240710	OMIM
G	Sct	secretin			ISS	1	201,472,250	201,472,944	RGD:7240710	OMIM
LEOPARD Syndrome
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Ptpn11	protein tyrosine phosphatase, non-receptor type 11			ISS	12	36,501,886	36,558,055	RGD:7240710	OMIM
G	Raf1	v-raf-leukemia viral oncogene 1			ISS	4	151,752,583	151,775,609	RGD:7240710	OMIM
LEOPARD SYNDROME 3
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Braf	v-raf murine sarcoma viral oncogene homolog B1			ISS	4	67,117,759	67,243,058	RGD:7240710	OMIM
LEOPARD syndrome, 1
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Ptpn11	protein tyrosine phosphatase, non-receptor type 11			ISS	12	36,501,886	36,558,055	RGD:7240710	OMIM
LEOPARD syndrome, 2
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Raf1	v-raf-leukemia viral oncogene 1			ISS	4	151,752,583	151,775,609	RGD:7240710	OMIM
Lethal Arthrogryposis With Anterior Horn Cell Disease
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Gle1	GLE1 RNA export mediator homolog (yeast)			ISS	3	8,924,783	8,948,712	RGD:7240710	OMIM
Lethal Congenital Contractural Syndrome 3
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Pip5k1c	phosphatidylinositol-4-phosphate 5-kinase, type I, gamma			ISS	7	9,881,767	9,909,651	RGD:7240710	OMIM
Lethal congenital contracture syndrome 1
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Gle1	GLE1 RNA export mediator homolog (yeast)			ISS	3	8,924,783	8,948,712	RGD:7240710	OMIM
Lethal Congenital Contracture Syndrome 2
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Erbb3	v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian)			ISS	7	1,858,057	1,877,353	RGD:7240710	OMIM
LIG4 Syndrome
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Lig4	ligase IV, DNA, ATP-dependent			ISS	16	84,881,880	84,888,448	RGD:7240710	OMIM
Limb Deformities, Congenital
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Bmpr1b	bone morphogenetic protein receptor, type IB			ISS	2	239,727,569	239,767,802	RGD:1334470	RGD
G	Gdf5	growth differentiation factor 5			ISS				RGD:704404	RGD
G	Hoxa13	homeo box A13			ISS	4	80,558,841	80,561,053	RGD:1599526	RGD
G	Irf6	interferon regulatory factor 6			ISS	13	108,986,973	109,006,180	RGD:1600214	RGD
Q	Plsm3	Polydactyly-luxate syndrome (PLS) morphotypes QTL 3			IAGP	7	1	35,575,619	RGD:632346	RGD
Limb-girdle muscular dystrophy type 2A
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Capn3	calpain 3			ISS	3	106,946,878	106,998,274	RGD:7240710	OMIM
Limb-girdle muscular dystrophy type 2F
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Sgcd	sarcoglycan, delta (dystrophin-associated glycoprotein)			ISS	10	32,084,678	32,489,330	RGD:7240710	OMIM
Limb-girdle muscular dystrophy type 2H
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Trim32	tripartite motif-containing 32			ISS	5	82,380,439	82,391,290	RGD:7240710	OMIM
Limb-girdle muscular dystrophy, type 1B
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Lmna	lamin A/C			ISS	2	180,595,724	180,616,354	RGD:7240710	OMIM
Limb-girdle muscular dystrophy, type 2B
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Dysf	dysferlin			ISS	4	118,213,435	118,371,283	RGD:7240710	OMIM
Limb-girdle muscular dystrophy, type 2C
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Scg3	secretogranin III			ISS	8	80,467,921	80,514,192	RGD:7240710	OMIM
G	Sgcg	sarcoglycan, gamma (dystrophin-associated glycoprotein)			ISS	15	40,363,607	40,410,061	RGD:7240710	OMIM
Limb-girdle muscular dystrophy, type 2D
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Sgca	sarcoglycan, alpha (dystrophin-associated glycoprotein)			ISS	10	83,647,336	83,660,800	RGD:7240710	OMIM
Limb-girdle muscular dystrophy, type 2E
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Sgcb	sarcoglycan, beta (dystrophin-associated glycoprotein)			ISS	14	36,959,920	36,974,916	RGD:7240710	OMIM
Limb-mammary syndrome
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Tp63	tumor protein p63			ISS	11	76,900,622	77,200,251	RGD:7240710	OMIM
Loeys-Dietz Syndrome, Type 1b
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Tgfbr2	transforming growth factor, beta receptor II			ISS	8	120,593,595	120,680,453	RGD:7240710	OMIM
Lujan Fryns syndrome
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Med12	mediator complex subunit 12			ISS	X	89,351,546	89,374,489	RGD:7240710	OMIM
Macrocephaly Autism Syndrome
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Pten	phosphatase and tensin homolog			ISS	1	236,771,027	236,837,261	RGD:7240710	OMIM
Macrocephaly, Alopecia, Cutis Laxa, and Scoliosis
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Rin2	Ras and Rab interactor 2			ISS	3	134,307,538	134,503,915	RGD:7240710	OMIM
Mandibuloacral dysplasia with type B lipodystrophy
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Zmpste24	zinc metallopeptidase STE24			ISS	5	141,644,119	141,677,211	RGD:7240710	OMIM
Mandibulofacial Dysostosis
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Acpp	acid phosphatase, prostate			ISS	8	109,354,381	109,400,296	RGD:1300346	RGD
G	Edn1	endothelin 1			ISS	17	28,303,886	28,309,775	RGD:734913	RGD
G	Fgfr2	fibroblast growth factor receptor 2			ISS	1	189,482,975	189,589,279	RGD:704404	RGD
G	Tcof1	Treacher Collins-Franceschetti syndrome 1			ISS	18	56,766,742	56,800,908	RGD:1599379	RGD
G	Tcof1	Treacher Collins-Franceschetti syndrome 1			ISS	18	56,766,742	56,800,908	RGD:7240710	OMIM
Mandibulofacial dysostosis, Treacher Collins type, autosomal recessive
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Polr1c	polymerase (RNA) I polypeptide C			ISS	9	10,298,309	10,302,421	RGD:7240710	OMIM
Marshall syndrome
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Col11a1	collagen, type XI, alpha 1			ISS	2	209,996,467	210,193,379	RGD:7240710	OMIM
Maxillofacial Abnormalities
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Col3a1	collagen, type III, alpha 1			IED	9	44,281,582	44,317,831	RGD:704391	RGD
McKusick Kaufman syndrome
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Mkks	McKusick-Kaufman syndrome			ISS	3	124,975,099	124,993,345	RGD:7240710	OMIM
Meckel Syndrome, Type 4
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Cep290	centrosomal protein 290			ISS	7	38,138,545	38,228,716	RGD:7240710	OMIM
Meier-Gorlin syndrome
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Cdc6	cell division cycle 6			ISS	10	87,684,493	87,697,865	RGD:7240710	OMIM
G	Cdt1	chromatin licensing and DNA replication factor 1			ISS	19	52,848,559	52,853,880	RGD:7240710	OMIM
G	Orc1	origin recognition complex, subunit 1			ISS	5	129,881,973	129,901,675	RGD:7240710	OMIM
G	Orc4	origin recognition complex, subunit 4			ISS	3	29,813,264	29,851,852	RGD:7240710	OMIM
G	Orc6	origin recognition complex, subunit 6			ISS	19	23,116,888	23,124,657	RGD:7240710	OMIM
MELAS Syndrome
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Mt-co3	mitochondrially encoded cytochrome c oxidase III			ISS	MT	8,599	9,382	RGD:5491184	RGD
G	Mt-nd1	mitochondrially encoded NADH dehydrogenase 1			ISS	MT	2,740	3,694	RGD:5490235	RGD
G	Mt-nd5	mitochondrially encoded NADH dehydrogenase 5			ISS	MT	11,736	13,565	RGD:5491173	RGD
G	Mt-nd5	mitochondrially encoded NADH dehydrogenase 5			ISS	MT	11,736	13,565	RGD:5491184	RGD
G	Mt-nd5	mitochondrially encoded NADH dehydrogenase 5			ISS	MT	11,736	13,565	RGD:5507825	RGD
Mental Retardation And Microcephaly With Pontine And Cerebellar Hypoplasia
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Cask	calcium/calmodulin-dependent serine protein kinase (MAGUK family)			ISS	X	20,910,960	21,250,869	RGD:7240710	OMIM
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Sobp	sine oculis-binding protein homolog (Drosophila)			ISS	20	46,918,487	47,079,823	RGD:7240710	OMIM
Mental Retardation, X-Linked 93
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Brwd3	bromodomain and WD repeat domain containing 3			ISS	X	97,008,947	97,131,275	RGD:7240710	OMIM
Mental Retardation, X-Linked, Syndromic, Christianson Type
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Slc9a6	solute carrier family 9, subfamily A (NHE6, cation proton antiporter 6), member 6			ISS	X	141,146,237	141,201,234	RGD:7240710	OMIM
Metaphyseal Anadysplasia 2
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Mmp9	matrix metallopeptidase 9			ISS	3	155,985,473	155,993,433	RGD:7240710	OMIM
Microcephalic Osteodysplastic Primordial Dwarfism, Type II
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Pcnt	pericentrin			ISS	20	12,608,650	12,694,390	RGD:7240710	OMIM
Microcephaly
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Arfgef2	ADP-ribosylation factor guanine nucleotide-exchange factor 2 (brefeldin A-inhibited)			ISS	3	157,967,942	158,051,359	RGD:1300288	RGD
G	Aspm	asp (abnormal spindle) homolog, microcephaly associated (Drosophila)		Susceptibility	ISS	13	52,811,658	52,860,925	RGD:1599300	RGD
G	Pqbp1	polyglutamine binding protein 1			ISS	X	26,638,460	26,642,640	RGD:7240710	OMIM
G	Slc25a19	solute carrier family 25 (mitochondrial thiamine pyrophosphate carrier), member 19			ISS	10	105,694,526	105,707,452	RGD:1624242	RGD
S	WI-Cit^fhJjloRrrc	flathead rat			TAS				RGD:2292495	RGD
MICROCEPHALY 1, PRIMARY, AUTOSOMAL RECESSIVE
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Mcph1	microcephalin 1			ISS	16	75,839,877	76,026,968	RGD:7240710	OMIM
MICROCEPHALY 2, PRIMARY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT CORTICAL MALFORMATIONS
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Wdr62	WD repeat domain 62			ISS	1	85,448,728	85,482,510	RGD:7240710	OMIM
MICROCEPHALY 3, PRIMARY, AUTOSOMAL RECESSIVE
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Cdk5rap2	CDK5 regulatory subunit associated protein 2			ISS	5	87,564,010	87,738,257	RGD:7240710	OMIM
MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Casc5	cancer susceptibility candidate 5			ISS	3	105,561,365	105,615,047	RGD:7240710	OMIM
G	Cep152	centrosomal protein 152			ISS	3	112,864,055	112,929,038	RGD:7240710	OMIM
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Aspm	asp (abnormal spindle) homolog, microcephaly associated (Drosophila)			ISS	13	52,811,658	52,860,925	RGD:7240710	OMIM
MICROCEPHALY 6, PRIMARY, AUTOSOMAL RECESSIVE
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Cenpj	centromere protein J			ISS	15	35,487,198	35,550,034	RGD:7240710	OMIM
MICROCEPHALY 7, PRIMARY, AUTOSOMAL RECESSIVE
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Stil	Scl/Tal1 interrupting locus			ISS	5	135,365,417	135,416,566	RGD:7240710	OMIM
MICROCEPHALY, POSTNATAL PROGRESSIVE, WITH SEIZURES AND BRAIN ATROPHY
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Med17	mediator complex subunit 17			ISS	8	12,062,713	12,081,709	RGD:7240710	OMIM
Microphthalmia, Syndromic 6
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Bmp4	bone morphogenetic protein 4			ISS	15	22,283,171	22,286,757	RGD:7240710	OMIM
Microtia, Hearing Impairment, And Cleft Palate
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Hoxa2	homeo box A2			ISS	4	80,462,651	80,464,927	RGD:7240710	OMIM
Minicore Myopathy with External Ophthalmoplegia
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Ryr1	ryanodine receptor 1 (skeletal)			ISS	1	84,116,098	84,254,503	RGD:7240710	OMIM
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Tk2	thymidine kinase 2, mitochondrial			ISS	19	667,538	689,556	RGD:7240710	OMIM
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE)
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Polg	polymerase (DNA directed), gamma			ISS	1	135,197,075	135,212,178	RGD:7240710	OMIM
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH METHYLMALONIC ACIDURIA)
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Sucla2	succinate-CoA ligase, ADP-forming, beta subunit			ISS	15	54,214,262	54,267,830	RGD:7240710	OMIM
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Rrm2b	ribonucleotide reductase M2 B (TP53 inducible)			ISS	7	73,432,161	73,459,541	RGD:7240710	OMIM
Mitochondrial Encephalomyopathies
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Tymp	thymidine phosphorylase			ISS	7	127,666,518	127,671,624	RGD:1601000	RGD
Mitochondrial encephalopathy
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Mt-nd3	mitochondrially encoded NADH dehydrogenase 3			ISS	MT	9,451	9,798	RGD:5507824	RGD
G	Mt-nd5	mitochondrially encoded NADH dehydrogenase 5			ISS	MT	11,736	13,565	RGD:5491186	RGD
G	Mt-nd6	mitochondrially encoded NADH dehydrogenase 6			ISS	MT	13,543	14,061	RGD:5491186	RGD
Mitochondrial Myopathies
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Slc25a4	solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4			ISS	16	49,353,476	49,357,271	RGD:1580619	RGD
G	Vdac1	voltage-dependent anion channel 1			ISS	10	37,795,721	37,823,253	RGD:7240710	OMIM
Miyoshi myopathy
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Dysf	dysferlin			ISS	4	118,213,435	118,371,283	RGD:7240710	OMIM
Mowat-Wilson syndrome
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Zeb2	zinc finger E-box binding homeobox 2			ISS	3	25,513,009	25,654,964	RGD:7240710	OMIM
Muenke Syndrome
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Fgfr3	fibroblast growth factor receptor 3			ISS	14	82,683,191	82,697,229	RGD:7240710	OMIM
MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Chrna1	cholinergic receptor, nicotinic, alpha 1 (muscle)			ISS	3	56,087,754	56,102,821	RGD:7240710	OMIM
G	Chrnd	cholinergic receptor, nicotinic, delta (muscle)			ISS	9	85,996,421	86,004,839	RGD:7240710	OMIM
G	Chrng	cholinergic receptor, nicotinic, gamma (muscle)			ISS	9	86,012,089	86,018,199	RGD:7240710	OMIM
Multiple synostoses syndrome 1
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Nog	noggin			ISS	10	77,689,244	77,690,871	RGD:7240710	OMIM
Multiple synostoses syndrome 2
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Gdf5	growth differentiation factor 5			ISS				RGD:7240710	OMIM
Multiple Synostoses Syndrome 3
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Fgf9	fibroblast growth factor 9			ISS	15	37,115,068	37,155,652	RGD:7240710	OMIM
Muscle Spasticity
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Adra2a	adrenoceptor alpha 2A			IEP				RGD:6480106	RGD
G	Tpp1	tripeptidyl peptidase I			ISS	1	163,490,394	163,496,517	RGD:734785	RGD
Muscle Weakness
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Tnfrsf1a	tumor necrosis factor receptor superfamily, member 1a			ISS	4	162,172,563	162,185,252	RGD:5130943	RGD
Q	Ean1	Experimental allergic neuritis QTL 1			IAGP				RGD:2306736	RGD
Q	Ean2	Experimental allergic neuritis QTL 2			IAGP	4	82,700,691	96,313,512	RGD:2306769	RGD
Q	Ean3	Experimental allergic neuritis QTL 3			IAGP	10	50,014,368	70,229,954	RGD:2306769	RGD
Q	Ean4	Experimental allergic neuritis QTL 4			IAGP	10	87,849,516	98,392,508	RGD:2306769	RGD
Q	Ean5	Experimental allergic neuritis QTL 5			IAGP	10	76,043,832	98,392,296	RGD:2306769	RGD
Q	Ean6	Experimental allergic neuritis QTL 6			IAGP	12	20,932,559	25,367,251	RGD:2306769	RGD
Muscular Diseases
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Ampd3	adenosine monophosphate deaminase 3			ISS	1	168,519,462	168,568,291	RGD:734568	RGD
G	Atp2a1	ATPase, Ca++ transporting, cardiac muscle, fast twitch 1			ISS				RGD:734618	RGD
G	Clu	clusterin			ISS	15	45,365,779	45,405,314	RGD:1626306	RGD
G	Col6a1	collagen, type VI, alpha 1		Susceptibility	IAGP	20	12,320,102	12,338,500	RGD:1600934	RGD
G	Cpt2	carnitine palmitoyltransferase 2			ISS	5	129,007,685	129,025,501	RGD:734814	RGD
G	Hmgcr	3-hydroxy-3-methylglutaryl-CoA reductase			ISS	2	27,127,504	27,149,580	RGD:5508448	RGD
G	Itga7	integrin, alpha 7			ISS	7	2,230,747	2,269,403	RGD:1600024	RGD
G	Lpl	lipoprotein lipase			ISS	16	22,533,105	22,556,905	RGD:1302535	RGD
G	Myh7	myosin, heavy chain 7, cardiac muscle, beta			ISS	15	33,072,928	33,094,595	RGD:1580927	RGD
G	Prkcd	protein kinase C, delta			IEP	16	5,954,218	5,975,743	RGD:1642535	RGD
G	Sox6	SRY (sex determining region Y)-box 6			ISS	1	173,556,966	174,069,437	RGD:1580857	RGD
G	Tubg1	tubulin, gamma 1			ISS	10	90,137,813	90,144,403	RGD:1626306	RGD
Muscular Dystrophies
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Capn3	calpain 3		Susceptibility	ISS	3	106,946,878	106,998,274	RGD:1600769	RGD
G	Capn3	calpain 3			ISS	3	106,946,878	106,998,274	RGD:734687	RGD
G	Cav3	caveolin 3		Susceptibility	ISS	4	148,294,428	148,310,380	RGD:1599529	RGD
G	Cav3	caveolin 3			ISS	4	148,294,428	148,310,380	RGD:7240710	OMIM
G	Chkb	choline kinase beta			ISS	7	127,746,749	127,750,104	RGD:6483361	RGD
G	Chkb	choline kinase beta			ISS	7	127,746,749	127,750,104	RGD:6483363	RGD
G	Col6a2	collagen, type VI, alpha 2		Susceptibility	ISS	20	12,436,783	12,464,512	RGD:1600934	RGD
G	Col6a3	collagen, type VI, alpha 3		Susceptibility	ISS	9	89,990,129	90,043,697	RGD:1600940	RGD
G	Dysf	dysferlin			ISS	4	118,213,435	118,371,283	RGD:1598789	RGD
G	Fkrp	fukutin related protein			ISS	1	77,133,884	77,139,485	RGD:1598944	RGD
G	Fktn	fukutin			ISS	5	71,155,051	71,208,525	RGD:1598929	RGD
G	Lama2	laminin, alpha 2		Susceptibility	ISS	1	18,203,466	18,885,462	RGD:1600200	RGD
G	Large	like-glycosyltransferase			ISS	19	12,043,818	12,497,663	RGD:1358756	RGD
G	Large	like-glycosyltransferase			ISS	19	12,043,818	12,497,663	RGD:1358757	RGD
G	Myot	myotilin			ISS	18	38,004,000	38,023,531	RGD:1599673	RGD
G	Pabpn1	poly(A) binding protein, nuclear 1			ISS	15	32,994,493	32,999,104	RGD:704404	RGD
G	Pomgnt1	protein O-linked mannose beta1,2-N-acetylglucosaminyltransferase			ISS	5	136,429,379	136,439,254	RGD:1599152	RGD
G	Sepn1	selenoprotein N, 1			ISS	5	153,295,598	153,308,305	RGD:1599352	RGD
G	Sgca	sarcoglycan, alpha (dystrophin-associated glycoprotein)			ISS	10	83,647,336	83,660,800	RGD:1599344	RGD
G	Sgca	sarcoglycan, alpha (dystrophin-associated glycoprotein)			ISS	10	83,647,336	83,660,800	RGD:1599345	RGD
G	Sgcd	sarcoglycan, delta (dystrophin-associated glycoprotein)			ISS	10	32,084,678	32,489,330	RGD:1599341	RGD
G	Trim32	tripartite motif-containing 32		Susceptibility	ISS	5	82,380,439	82,391,290	RGD:1624127	RGD
Muscular dystrophy congenital, merosin negative
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Bche	butyrylcholinesterase			ISS	2	164,329,613	164,427,994	RGD:5688132	RGD
G	Lama2	laminin, alpha 2			ISS	1	18,203,466	18,885,462	RGD:7240710	OMIM
Muscular Dystrophy, Congenital, Due To Integrin Alpha-7 Deficiency
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Itga7	integrin, alpha 7			ISS	7	2,230,747	2,269,403	RGD:7240710	OMIM
Muscular Dystrophy, Congenital, Lmna-Related
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Lmna	lamin A/C			ISS	2	180,595,724	180,616,354	RGD:7240710	OMIM
Muscular Dystrophy, Duchenne
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Dmd	dystrophin			ISS	X	71,501,362	71,671,414	RGD:1580859	RGD
G	Dmd	dystrophin			ISS	X	71,501,362	71,671,414	RGD:7240710	OMIM
G	Timp2	TIMP metallopeptidase inhibitor 2			ISS	10	108,310,473	108,358,821	RGD:1580161	RGD
G	Utrn	utrophin			ISS	1	7,099,840	7,614,980	RGD:737706	RGD
Muscular Dystrophy, Emery-Dreifuss
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Emd	emerin			ISS	X	160,351,228	160,354,239	RGD:1598907	RGD
G	Emd	emerin			ISS	X	160,351,228	160,354,239	RGD:7240710	OMIM
G	Lmna	lamin A/C			ISS	2	180,595,724	180,616,354	RGD:1580516	RGD
G	Lmna	lamin A/C			ISS	2	180,595,724	180,616,354	RGD:7240710	OMIM
G	Syne1	spectrin repeat containing, nuclear envelope 1			ISS	1	35,803,552	36,269,628	RGD:7240710	OMIM
Muscular Dystrophy, Facioscapulohumeral
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Slc25a4	solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4			ISS	16	49,353,476	49,357,271	RGD:1580621	RGD
Muscular dystrophy, limb-girdle, type 1A
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Myot	myotilin			ISS	18	38,004,000	38,023,531	RGD:7240710	OMIM
Muscular Dystrophy, Limb-Girdle, Type 1C
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Cav3	caveolin 3			ISS	4	148,294,428	148,310,380	RGD:7240710	OMIM
Muscular Dystrophy, Limb-Girdle, Type 2G
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Tcap	titin-cap			ISS				RGD:7240710	OMIM
Muscular Dystrophy, Limb-Girdle, Type 2J
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Ttn	titin			ISS	3	59,404,023	59,665,308	RGD:7240710	OMIM
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2Q
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Plec	plectin			ISS	7	114,202,742	114,262,385	RGD:7240710	OMIM
Muscular Dystrophy, Oculopharyngeal
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Pabpn1	poly(A) binding protein, nuclear 1			ISS	15	32,994,493	32,999,104	RGD:7240710	OMIM
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 1
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Pomt1	protein-O-mannosyltransferase 1			ISS	3	11,348,786	11,366,633	RGD:7240710	OMIM
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 2
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Pomt2	protein-O-mannosyltransferase 2			ISS	6	111,242,085	111,259,180	RGD:7240710	OMIM
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Fktn	fukutin			ISS	5	71,155,051	71,208,525	RGD:7240710	OMIM
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Fkrp	fukutin related protein			ISS	1	77,133,884	77,139,485	RGD:7240710	OMIM
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 6
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Large	like-glycosyltransferase			ISS	19	12,043,818	12,497,663	RGD:7240710	OMIM
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Pomt1	protein-O-mannosyltransferase 1			ISS	3	11,348,786	11,366,633	RGD:7240710	OMIM
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Pomt2	protein-O-mannosyltransferase 2			ISS	6	111,242,085	111,259,180	RGD:7240710	OMIM
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 3
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Pomgnt1	protein O-linked mannose beta1,2-N-acetylglucosaminyltransferase			ISS	5	136,429,379	136,439,254	RGD:7240710	OMIM
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Large	like-glycosyltransferase			ISS	19	12,043,818	12,497,663	RGD:7240710	OMIM
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH OR WITHOUT MENTAL RETARDATION), TYPE B, 5
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Fkrp	fukutin related protein			ISS	1	77,133,884	77,139,485	RGD:7240710	OMIM
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITHOUT MENTAL RETARDATION), TYPE B, 4
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Fktn	fukutin			ISS	5	71,155,051	71,208,525	RGD:7240710	OMIM
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 1
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Pomt1	protein-O-mannosyltransferase 1			ISS	3	11,348,786	11,366,633	RGD:7240710	OMIM
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 2
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Pomt2	protein-O-mannosyltransferase 2			ISS	6	111,242,085	111,259,180	RGD:7240710	OMIM
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 3
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Pomgnt1	protein O-linked mannose beta1,2-N-acetylglucosaminyltransferase			ISS	5	136,429,379	136,439,254	RGD:7240710	OMIM
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 4
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Fktn	fukutin			ISS	5	71,155,051	71,208,525	RGD:7240710	OMIM
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 5
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Fkrp	fukutin related protein			ISS	1	77,133,884	77,139,485	RGD:7240710	OMIM
Musculoskeletal Abnormalities
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Arc	activity-regulated cytoskeleton-associated protein			ISS	7	112,771,937	112,775,381	RGD:734603	RGD
G	Epas1	endothelial PAS domain protein 1			ISS	6	10,203,108	10,297,215	RGD:734934	RGD
G	Lmbr1	limb region 1 homolog (mouse)			ISS	4	1,177,941	1,344,583	RGD:1600688	RGD
G	Por	P450 (cytochrome) oxidoreductase			ISS	12	22,078,629	22,097,301	RGD:1599697	RGD
Myofascial Pain Syndromes
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Ngf	nerve growth factor (beta polypeptide)			IEP	2	197,621,726	197,632,960	RGD:5144120	RGD
G	Ntrk1	neurotrophic tyrosine kinase, receptor, type 1			IPM	2	179,838,740	179,855,545	RGD:5684340	RGD
Myoglobinuria
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Pgam2	phosphoglycerate mutase 2 (muscle)			ISS	14	86,466,055	86,468,166	RGD:1599129	RGD
G	Pgk1	phosphoglycerate kinase 1			ISS	X	94,324,219	94,340,193	RGD:1599120	RGD
Myoglobinuria, Acute Recurrent, Autosomal Recessive
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Lpin1	lipin 1			ISS	6	40,253,664	40,297,195	RGD:7240710	OMIM
Myopathies, Nemaline
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Acta1	actin, alpha 1, skeletal muscle			ISS	19	54,081,496	54,084,508	RGD:1559154	RGD
G	Acta1	actin, alpha 1, skeletal muscle			ISS	19	54,081,496	54,084,508	RGD:7240710	OMIM
G	Ankrd1	ankyrin repeat domain 1			ISS	1	240,316,123	240,324,804	RGD:1578366	RGD
G	Neb	nebulin			ISS	3	33,634,963	33,833,113	RGD:7240710	OMIM
G	Tnnt1	troponin T type 1 (skeletal, slow)			ISS	1	68,036,411	68,045,142	RGD:737736	RGD
G	Tnnt1	troponin T type 1 (skeletal, slow)			ISS	1	68,036,411	68,045,142	RGD:7240710	OMIM
G	Tpm2	tropomyosin 2, beta			ISS	5	59,994,101	60,003,261	RGD:7240710	OMIM
G	Tpm3	tropomyosin 3		Susceptibility	ISS	2	182,303,994	182,324,994	RGD:1600404	RGD
G	Tpm3	tropomyosin 3			ISS	2	182,303,994	182,324,994	RGD:7240710	OMIM
Myopathies, Structural, Congenital
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Acta1	actin, alpha 1, skeletal muscle			ISS	19	54,081,496	54,084,508	RGD:1559154	RGD
G	Ankrd1	ankyrin repeat domain 1			ISS	1	240,316,123	240,324,804	RGD:1578366	RGD
G	Mtm1	myotubularin 1			ISS	7	247,960	265,281	RGD:1600519	RGD
G	Myf6	myogenic factor 6			ISS	7	46,199,972	46,201,867	RGD:1600529	RGD
Myopathy with lactic acidosis and sideroblastic anemia
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Pus1	pseudouridylate synthase 1			ISS	12	46,024,978	46,033,733	RGD:7240710	OMIM
G	Yars2	tyrosyl-tRNA synthetase 2 (mitochondrial)			ISS	11	86,609,037	86,614,799	RGD:7240710	OMIM
Myopathy with Lactic Acidosis, Hereditary
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Iscu	iron-sulfur cluster scaffold homolog (E. coli)			ISS	12	43,886,419	43,892,329	RGD:7240710	OMIM
Myopathy, Central Core
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Ryr1	ryanodine receptor 1 (skeletal)			ISS	1	84,116,098	84,254,503	RGD:7240710	OMIM
MYOPATHY, CENTRONUCLEAR, 1
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Dnm2	dynamin 2			ISS	8	20,527,130	20,610,749	RGD:7240710	OMIM
G	Mtmr14	myotubularin related protein 14			ISS	4	149,121,980	149,165,007	RGD:7240710	OMIM
MYOPATHY, CENTRONUCLEAR, 2
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Bin1	bridging integrator 1			ISS	18	24,813,407	24,872,852	RGD:7240710	OMIM
MYOPATHY, CENTRONUCLEAR, X-LINKED
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Mtm1	myotubularin 1			ISS	7	247,960	265,281	RGD:7240710	OMIM
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Acta1	actin, alpha 1, skeletal muscle			ISS	19	54,081,496	54,084,508	RGD:7240710	OMIM
G	Sepn1	selenoprotein N, 1			ISS	5	153,295,598	153,308,305	RGD:7240710	OMIM
G	Tpm3	tropomyosin 3			ISS	2	182,303,994	182,324,994	RGD:7240710	OMIM
Myopathy, Distal, with Anterior Tibial Onset
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Dysf	dysferlin			ISS	4	118,213,435	118,371,283	RGD:7240710	OMIM
Myopathy, Early-Onset, with Fatal Cardiomyopathy
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Ttn	titin			ISS	3	59,404,023	59,665,308	RGD:7240710	OMIM
Myopathy, Mitochondrial Progressive, With Congenital Cataract, Hearing Loss, And Developmental Delay
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Gfer	growth factor, augmenter of liver regeneration			ISS	10	13,946,311	13,948,665	RGD:7240710	OMIM
MYOPATHY, MYOFIBRILLAR 6, MFM6
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Bag3	Bcl2-associated athanogene 3			ISS	1	187,781,147	187,804,835	RGD:7240710	OMIM
MYOPATHY, MYOFIBRILLAR, 1
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Des	desmin			ISS	9	74,637,783	74,645,499	RGD:7240710	OMIM
MYOPATHY, MYOFIBRILLAR, 3
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Myot	myotilin			ISS	18	38,004,000	38,023,531	RGD:7240710	OMIM
MYOPATHY, MYOFIBRILLAR, 4
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Ldb3	LIM domain binding 3			ISS	16	10,221,362	10,247,798	RGD:7240710	OMIM
Myopathy, Myosin Storage
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Myh7	myosin, heavy chain 7, cardiac muscle, beta			ISS	15	33,072,928	33,094,595	RGD:7240710	OMIM
Myopathy, Reducing Body, X-Linked, Childhood-Onset
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Fhl1	four and a half LIM domains 1			ISS	X	141,315,765	141,329,278	RGD:7240710	OMIM
Myopathy, Reducing Body, X-Linked, Early-Onset, Severe
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Fhl1	four and a half LIM domains 1			ISS	X	141,315,765	141,329,278	RGD:7240710	OMIM
Myopathy, X-Linked, with Excessive Autophagy
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Vma21	VMA21 vacuolar H+-ATPase homolog (S. cerevisiae)			ISS	X	157,237,405	157,244,955	RGD:7240710	OMIM
Myopathy, X-Linked, With Postural Muscle Atrophy
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Fhl1	four and a half LIM domains 1			ISS	X	141,315,765	141,329,278	RGD:7240710	OMIM
Myosclerosis, Autosomal Recessive
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Col6a2	collagen, type VI, alpha 2			ISS	20	12,436,783	12,464,512	RGD:7240710	OMIM
Myositis
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Fcgr3a	Fc fragment of IgG, low affinity IIIa, receptor		Susceptibility	ISS	13	86,867,641	86,877,665	RGD:5508428	RGD
G	RT1-Ba	RT1 class II, locus Ba			ISS	20	4,697,971	4,702,564	RGD:5147793	RGD
G	RT1-Ba	RT1 class II, locus Ba			ISS	20	4,697,971	4,702,564	RGD:5147629	RGD
G	RT1-Ba	RT1 class II, locus Ba			ISS	20	4,697,971	4,702,564	RGD:5147869	RGD
G	RT1-Bb	RT1 class II, locus Bb			ISS	20	4,730,559	4,736,201	RGD:5147629	RGD
G	RT1-Db1	RT1 class II, locus Db1			ISS	20	4,671,489	4,681,058	RGD:5147629	RGD
G	RT1-Db1	RT1 class II, locus Db1			ISS	20	4,671,489	4,681,058	RGD:5147793	RGD
G	RT1-Db1	RT1 class II, locus Db1			ISS	20	4,671,489	4,681,058	RGD:5147568	RGD
Myositis Ossificans
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Acvr1	activin A receptor, type I			ISS	3	40,191,727	40,260,488	RGD:7240710	OMIM
G	Bmp2	bone morphogenetic protein 2			ISS	3	121,372,692	121,381,236	RGD:734647	RGD
G	Bmp4	bone morphogenetic protein 4			ISS	15	22,283,171	22,286,757	RGD:734648	RGD
Myositis, Inclusion Body
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Cd36	CD36 molecule (thrombospondin receptor)			ISS	4	13,471,878	13,525,620	RGD:6893508	RGD
G	Clu	clusterin			ISS	15	45,365,779	45,405,314	RGD:1626306	RGD
G	Gne	glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase			ISS	5	60,506,171	60,536,403	RGD:704404	RGD
G	Myh2	myosin, heavy chain 2, skeletal muscle, adult			ISS	10	53,864,777	53,891,711	RGD:1600532	RGD
G	Sod2	superoxide dismutase 2, mitochondrial			ISS	1	41,862,997	41,870,327	RGD:1581257	RGD
G	Tubg1	tubulin, gamma 1			ISS	10	90,137,813	90,144,403	RGD:1626306	RGD
G	Vcp	valosin-containing protein			ISS	5	59,472,100	59,491,508	RGD:1599735	RGD
Myotonia Congenita
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Clcn1	chloride channel, voltage-sensitive 1			IED	4	70,052,319	70,081,449	RGD:704389	RGD
MYOTONIA CONGENITA, AUTOSOMAL DOMINANT
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Clcn1	chloride channel, voltage-sensitive 1			ISS	4	70,052,319	70,081,449	RGD:7240710	OMIM
Myotonia Congenita, Autosomal Recessive
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Clcn1	chloride channel, voltage-sensitive 1			ISS	4	70,052,319	70,081,449	RGD:7240710	OMIM
Myotonic Disorders
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Cryab	crystallin, alpha B			ISS	8	54,107,824	54,111,502	RGD:704404	RGD
G	Scn4a	sodium channel, voltage-gated, type IV, alpha subunit			ISS	10	95,710,710	95,760,323	RGD:7240710	OMIM
Myotonic Dystrophy
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Dmpk	dystrophia myotonica-protein kinase			ISS	1	78,449,324	78,450,578	RGD:1600900	RGD
Nemaline myopathy 1
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Tpm3	tropomyosin 3			ISS	2	182,303,994	182,324,994	RGD:7240710	OMIM
Nemaline Myopathy 2
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Neb	nebulin			ISS	3	33,634,963	33,833,113	RGD:7240710	OMIM
Nemaline myopathy 3
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Acta1	actin, alpha 1, skeletal muscle			ISS	19	54,081,496	54,084,508	RGD:7240710	OMIM
Nemaline myopathy 4
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Tpm2	tropomyosin 2, beta			ISS	5	59,994,101	60,003,261	RGD:7240710	OMIM
Nemaline myopathy 5